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Dynein Mutation, Abnormal Rear Leg (Arl) 
 
Abstract 
 
The aim of this project was to investigate the effects of a novel mouse cytoplasmic 
dynein mutation; Abnormal rear leg (Arl).  Cytoplasmic dynein is a microtubule 
(MT) based motor protein important for diverse cellular processes including Golgi 
maintenance and retrograde transport of organelles.  Arl is a mouse point mutation 
in the heavy chain subunit of dynein (Dync1h1). Homozygous Dync1h1
Arl/Arl
 die at 
embryonic day 10.  Dync1h1
Arl/+
 heterozygotes have a normal life span, but exhibit 
abnormal gait and hindlimb clasping during tail suspension, typical of neuronal 
dysfunction.  Protein purification from wildtype and heterozygous brain tissue 
showed increased MT binding in Dync1h1
Arl/+
 compared to wildtype.  Delayed 
endosomal trafficking was observed in EGF stimulated Dync1h1
Arl/+
 mouse 
embryonic fibroblasts (MEFs) compared to wildtype, in both fixed cells and using 
live cell imaging.  Similarly, a delay in the reassembly of the Golgi complex after 
disruption with a MT depolymerisation agent, nocodazole, was observed in 
Dync1h1
Arl/+
 MEFs compared to wildtype.  In addition, the Golgi complex was 
observed as being structurally perturbed in Dync1h1
Arl/+
 lumbar spinal cord neurons 
using transmission electron microscopy (TEM) compared to the wildtype.  TEM 
also revealed that the mitochondria were structurally perturbed in Dync1h1
Arl/+
 
lumbar spinal cord neurons compared to wildtype, and O2 consumption assays 
investigating their function showed the Dync1h1
Arl/+
 mitochondria to have increased 
respiration rates compared to wildtype.  Thus, these data highlight the Arl mouse as 
an invaluable model for studying the mechanism of dynein function and the 
subsequent outcomes when they are compromised. 
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 Chapter I 
 
 
INTRODUCTION 
 
 
 
I.1  Motor Proteins 
 
The often large size and complex organisation of eukaryotic cells requires a system of 
efficient directed transport.  This transport is provided by motor proteins that power the 
movements of subcellular components such as organelles and chromosomes.  
Movement is along the two polarised cytoskeletal fibres - actin filaments and 
microtubules. 
  
There are three families of motor proteins; myosins, kinesins and dyneins.  Kinesins 
and dyneins move along MTs, with kinesins mainly moving towards the plus ends 
(anterograde transport) and the majority of dyneins moving towards the minus end 
(retrograde transport).  Most myosins move along actin filaments towards the barbed, 
plus end. 
 
I.2  Dyneins 
 
There are two classes of dyneins - axonemal dyneins are responsible for the movements 
of cilia and flagella, while cytoplasmic dyneins are involved in a number of processes, 
for example, transport of organelles, nuclear migration and mitosis. 
 
Cytoplasmic dynein has two forms, designated as cytoplasmic dynein 1 and 2.  
Cytoplasmic dynein 2 is involved in retrograde intraflagella transport (IFT), a process 
required for assembly and maintenance of lower eukaryotic cilium/flagellum, first 
identified in Chlamydomonas (Pazour, Dickert et al. 1999; Porter, Bower et al. 1999).  
It is now also well established in the generation and maintenance of mammalian cilia 
(Grissom, Vaisberg et al. 2002; Mikami, Tynan et al. 2002; Perrone, Tritschler et al. 
2003).  Cytoplasmic dynein 1 is the more abundant of the two complexes and is 
responsible for multiple activities such as transport of organelles, chromosome 
segregation and positioning of Golgi apparatus. 
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I.2.1  Cytoplasmic dynein 
I.2.1.1  Dynein Heavy Chain 
 
Dyneins are members of the AAA family (ATPase associated with various cellular 
activities) of ATPases (Neuwald, Aravind et al. 1999).  They consist of extremely large 
heavy chains of more than 500kDa each.  The C terminal 380kDa fragment contains the 
motor domain with the C terminal 2350 residues forming 6 linked AAA modules 
(AAA1-AAA6) each 35-40kDa in a ring structure.  There is also thought to be a 
seventh domain, C terminal to AAA6 which is not an AAA module. When a truncated 
motor domain was engineered without the C terminal sequence, the overall motor 
domain structure under EM was mainly unchanged and no gap was left in the ring, 
which would be expected if it were a heptameric ring structure (Roberts, Numata et al. 
2009). The ring consisting of the six AAA modules forms the globular head of dynein.  
Between the AAA4 and AAA5 modules, the dynein heavy chain forms a rod-like loop 
with a small, globular, ATP-sensitive microtubule-binding site at the tip.  The stalk, or 
the stem, is formed by an anti-parallel coil of the folded back heavy chain and can be up 
to 15nm in length (Gee, Heuser et al. 1997).  
 
 
Figure 1.  Schematic of cytoplasmic dynein.  
Schematic diagram of cytoplasmic dynein showing dimerised heavy chains and sites of accessory chain 
binding.  Adapted from (Vale 2003).  LIC refers to light intermediate chain, IC refers to intermediate 
chain and LC refers to light chain of the dynein complex. 
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The N terminal 1800 residues form a tail that interacts with accessory chains and cargo.  
Modules 1 to 4 bind ATP, but only AAA1, nearest the N terminus, hydrolyses ATP 
during the interactions with microtubules that generate movement (Gibbons, Lee-Eiford 
et al. 1987; Ogawa 1991; Gee, Heuser et al. 1997).  The other domains may regulate the 
ATPase cycle at AAA1.  These four modules contain a highly conserved Walker A 
motif, also called a P loop, and a Walker B motif. 
 
Walker motifs are 3 different, non-contiguous stretches of sequence known as Walker 
A, B and C that bind phosphates and are found in a number of ATP- and GTP-binding 
proteins. Walker A defines the binding site for the triphosphate and is important in the 
removal of the γ-phosphate of ATP during hydrolysis, and the B and C motifs interact 
with the base of the nucleotide (Gee, Heuser et al. 1997; Petsko and Ringe 2004).  
Evidence of a functional role for the first P loop came from molecular dissection of 
cytoplasmic dyneins in which mutation of the P loop caused loss of their motor 
activities (Silvanovich, Li et al. 2003). Dyneins have a high affinity for ADP bound to 
vanadate (vi), which can absorb light in the UV region.  Illumination of dynein bound 
to ADP-vi causes a break in the heavy chain near the AAA1 domain (Vallee and Hook 
2006). When the AAA1 was destroyed through UV photocleavage, most of the ATPase 
activity of the dynein was lost (Gibbons, Lee-Eiford et al. 1987).  It is thought that the 
other P loops have a regulatory role binding either ATP or ADP.  Removal of the 
extreme C-terminal portion of the heavy chain eliminates the AAA1 photocleavage by 
vanadate, suggesting the AAA ring needs to be intact to function fully (Gee, Heuser et 
al. 1997). 
 
More recently, Reck-Peterson and Vale have used systematic mutagenesis of nucleotide 
binding sites in the non-essential DYN1 gene of budding yeast to elucidate the functions 
of the individual AAA nucleotide binding sites. They showed that AAA2 and AAA4 
can be made hydrolysis-incompetent without affecting function, but ATP hydrolysis is 
required in AAA1 and AAA3 for dynein function.  Nucleotide binding at AAA2 and 
AAA4 is needed for maximal levels of MT binding in vitro (Reck-Peterson and Vale 
2004). 
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In cytoplasmic dynein the MT binding domain at the end of the stalk is far away from 
the site of ATP hydrolysis in the AAA ring.  This is in contrast to both myosins and 
kinesins, where the nucleotide binding site and filament binding site are relatively close 
together, allowing direct communication.  In dynein this may be dealt with by the 
ATPase activity affecting the MT binding through conformational changes in adjacent 
AAA domains that are passed around the ring structure. 
 
 
Figure 2.  Diagram showing arrangement of domains of C terminal of the heavy chain. 
Diagram showing the arrangement of the AAA domains, stalk and MTBD in the C-terminus of DHC.  
From (Roberts, Numata et al. 2009). 
 
Another suggestion of how MT-binding affinity could be affected by ATP-hydrolysis 
and/or the powerstroke which occurs from the stem, comes from axonemal dyneins.  In 
the axoneme, the globular heads appear to rotate during the mechanochemical cycle 
(Goodenough and Heuser 1984).  Thus, if the powerstroke of cytoplasmic dynein 
contained a rotary and linear component, the rigid MT-binding stalk would dramatically 
change its orientation in relation to the MT axis.  This could disrupt the interaction with 
the MT and cause a significant change in the affinity of the dynein stalk for the MT 
(King 2000). 
 
Gibbons et al (Gibbons, Garbarino et al. 2005) have suggested that the alignment of the 
two strands of the coiled-coil, CC1 and CC2, directly affects the affinity of the MT 
binding domain (MTBD) for MTs.  In using a number of expressed fragments that 
contained different lengths of the coiled-coils, which placed them out of alignment, the 
authors were able to show that only one conformation gave maximum MT binding, one 
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other gave intermediate binding, whilst all others showed greatly reduced affinity.  A 
model for how the coiled-coil stalk mediates “communication” between the ATP 
binding site and the MTBD proposes a small sliding movement between CC1 and CC2, 
changing the alignment and therefore the MTBD affinity for MTs.  
 
The “powerstroke mechanism” has become the generally accepted model for force 
generation in cytoplasmic dynein.  Using EM analysis of axonemal dynein, it has been 
proposed that the dynein tail assumes two different positions relative to the head - the 
prestroke or primed and poststroke or unprimed positions - depending on the binding of 
the nucleotides at the head (Imamula, Kon et al. 2007; Roberts, Numata et al. 2009).  
Burgess et al (Burgess, Walker et al. 2003) have shown that the stem and stalk are 
closer together in dynein-apo (136
o
) than dynein-ADP-vi molecules (160
o
).  As there 
was negligible change in the length of either the stalk or stem, it appeared the change in 
their relative distances must be due to translational movement between the two 
domains.  The tail therefore acts as a lever arm for the powerstroke due to 
conformational changes originating in the head.  Movement of the stalk in cytoplasmic 
dynein has also been seen to be nucleotide dependent, with a shift of 5nm in a 
clockwise direction upon nucleotide binding (Roberts, Numata et al. 2009). 
 
Whilst using a rare, long-stemmed form of axonemal dynein, termed dynein-c, it was 
noticed that there was often a sharp, approximately 90
o
 bend in the stem which 
corresponded to the position of the bend normally seen in typical molecules.  A 
previously unnoticed structure was seen between the bend and the head, of 
approximately 10nm in length and a width similar to the neck of 2 nm (Burgess, Walker 
et al. 2003). This structure was termed the linker and suggested to undergo a swinging 
movement across the head, depending on nucleotide binding, thus facilitating the 
powerstroke. 
 
Evidence for a linker domain in cytoplasmic dynein has recently been proposed.  To 
determine if a linker exists in cytoplasmic dynein, the function of the top of the stem 
was investigated.  A truncation construct of Dictyostelium discoideum that lacks 542 
residues N terminal to the AAA1 (ΔN) was engineered.  This region is known to be 
essential for motor activity.  Using negative stain EM, removal of the N terminal 
sequence changed the shape of the ring structure of the head, causing it to become more 
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symmetrical in shape with well defined “wedge-shaped” domains (Roberts, Numata et 
al. 2009).  Fusion proteins were also constructed, in which GFP and BFP were inserted 
at specific locations in the motor domain sequence, including the N terminal region at 
residue 1383, allowing the location of the N terminal to be mapped by EM.  In 
unprimed motor the N terminal region tag was consistently found close to the periphery 
of the head near the base of the stalk at AAA4, which is close to the tail-linker junction 
in axonemal dynein-c, suggesting that a similar linker exists in cytoplasmic dynein.  
When ATP and vanadate were added to form the primed conformation, the N terminal 
tag shifted towards AAA2 by a distance of approximately 16-18 nm.  Based on this, a 
model is proposed where the linker portion of the N terminal is closest to AAA2 when 
ATP is bound to the motor (prestroke or primed conformation) then, during the 
powerstroke the linker swings across the head towards AAA4 pulling cytoplasmic 
dynein forwards, resulting in the post-stroke conformation (Roberts, Numata et al. 
2009).  
 
Figure 3.  Schematic demonstrating the model for a linker domain in dynein powerstroke.   
The 6 AAA domains form a ring, with a 7
th
 non-AAA domain, here shown in shaded black.  The purple 
domain represents the linker which is positioned across the motor head from AAA1 (blue) to AAA4 
(yellow) when in the unprimed position.  This linker domain moves down across the ring towards AAA2 
(light blue) in the primed conformation, thus causing the N-terminus of DHC to move by ~17 nm [From 
(Roberts, Numata et al. 2009)]. 
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To investigate step size, Mallik et al (Mallik, Carter et al. 2004), used purified dynein 
bound to beads.  The beads allowed the position of the motor head to be tracked during 
the experiment.  An optical trap was used to determine the force exerted by dynein 
based on the distance moved at different stiffness of the trap.  It was found that the size 
of the step taken by dynein is dependent on the cargo load.  At low load, dynein took 
steps of 24 – 32 nm.  However, under high load (>0.8 pN) the step size measured was 8 
nm.  This suggests that dynein can act as a molecular gear where nucleotide binding at 
AAA1-AAA4 leads to a “tighter” conformation of the AAA ring, which results in a 
smaller, but stronger dynein step.  Kinesin takes 8 nm steps, so under low load, the 32 
nm steps taken by dynein suggest that dynein can be four times more efficient, in terms 
of ATP usage, at transporting cargo, compared to kinesin (Mallik, Carter et al. 2004). 
 
 I.2.1.2  Dynein Accessory Chains 
 
At the N-terminal base of the heavy chain stems there are a number of accessory chains.  
These comprise a number of intermediate, light intermediate and light chains.  At least 
10 genes are known to encode the components of the dynein complex (King, Bonilla et 
al. 2002). 
 
The intermediate chains are 70-74kDa polypeptides that are encoded by 2 genes, 
Dync1i1 (encoding DYNC1I1, from this point onwards referred to as IC1) and Dync1i2 
(encoding DYNC1I2, from this point onward represented as IC2), which undergo much 
splicing and phosphorylation to produce a number of structural isoforms.  Nurminsky et 
al have shown, using Drosophila, that there are at least 10 structural isoforms of IC 
produced by alternative splicing from one IC gene, and that the splicing is tissue 
specific.  The variation in structure of the isoforms is specific to the N-terminus of the 
IC, where it interacts with dynactin, the dynein activator, suggesting differences in the 
dynactin-mediated organelle binding by IC isoforms (Nurminsky, Nurminskaya et al. 
1998).    
 
More recently, Kuta (Kuta, Deng et al. 2010), have reported new splice isoforms for 
both IC genes and detailed the expression of isoforms in a range of mouse embryonic 
and adult tissues.  Their data corroborates the theory that alternative splicing of the N-
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terminus of ICs is important for dynein function.  Neural specific isoforms identified 
indicate that specialised regulation may occur in neurons. 
 
The conserved N-terminus of IC interacts with dynactin (King, Bonilla et al. 2002) 
while the C-terminus contains multiple WD repeats that are thought to fold into a β-
propeller structure.  This predicted domain is conserved between all ICs (cytoplasmic 
and axonemal) and is thought to play a part in subunit-subunit interactions with the 
dynein molecule (Paschal, Mikami et al. 1992; King, Bonilla et al. 2002). 
 
The light intermediate chains are 52-61 kDa polypeptides with 2 genes Dync1li1 
(encoding DYNC1LI1, referred to from now as LIC1) and Dync1li2 (encoding 
DYNC1LI2, referred to now as LIC2), which through alternative splicing give rise to at 
least seven isoforms.  The LIC chains bind directly to the heavy chain and are thought 
to interact with cargos, as LIC1 chains have been shown to directly interact with 
pericentrin, a centrosomal protein.  This suggests LICs may have a cargo targeting 
function (Tynan, Gee et al. 2000). 
 
Studies performed in COS7 cells have demonstrated that LICs bind directly to the N-
terminus of the HCs, adjacent to and overlapping with the IC binding site.  No direct 
interaction has been seen, but both ICs and LICs are present in the same complexes, 
suggesting that LICs and ICs need to be independently located on DHC to allow 
necessary interactions with other proteins, but without sterically interfering with each 
other (Tynan, Gee et al. 2000). 
 
The light chains (referred to from now as LC) are 10-13 kDa polypeptides, thought to 
be encoded by three gene families and currently accepted to contain 6 different genes 
(See refs included in (Banks, Bros-Facer et al. 2009).  The gene families are, Tctex1 (t), 
Roadblock (rb) and LC8 (l).  Current evidence suggests that LCs are common to 
cytoplasmic and some axonemal dyneins (King, Bonilla et al. 2002), therefore they are 
designated as: Dynlt1 (referred to as Tctex1), Dynlt3 (rp3), Dynlrb1 (Robl1), Dynrb2 
(Robl2), Dynll1 (LC8-1) and Dynll2 (LC8-2) (Pfister, Fisher et al. 2005).  However, 
some variation in nomenclature still exists.  
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Both Tctex-1 and LC8 have very similar structures and are homodimers in solution 
(King, Bonilla et al. 2002).  They both bind ICs at non-overlapping sites that have 
sequence homology.  Tctex-1 has some role in cargo binding as it has been shown to 
directly interact with retinal opsin and is needed for correct opsin localisation (Tai et al 
2001).  LC8 interacts with a number of other polypeptides, but these have not yet been 
confirmed as definite cargos of dynein. 
 
Different isoforms of the dynein complex may exist, as components of the complex are 
differentially expressed in different tissues.  This suggests that dynein complexes 
consisting of different combinations of subunits may exist (Vaughan and Vallee 1995; 
Vaisberg, Grissom et al. 1996; King, Barbarese et al. 1998).  The variety in composition 
of dynein sub-complexes may allow for the large range of cargos that it binds and 
transports. 
 
I.2.2  Dynein in neurons 
 
Co-ordinated active transport systems are extremely important in neurons due to their 
enormous size in comparison to other somatic cells.  Neurons are numerous in size and 
shape, but can have tremendously long axons and the neuronal cytoskeleton is 
exceptionally important in maintaining the specialised and polarised morphology 
necessary for their proper functioning. 
 
The neuronal cytoskeleton is comprised of networks similar to those in non-neuronal 
cells, such as actin filaments and MTs, but also contains specialised intermediate 
filaments known as neurofilaments.  The actin filaments are important during 
development for axonal outgrowth and cell motility, and in mature neurons for integrity 
of the cell.  Actin filaments can also provide tracks for short range movement by 
myosins for distribution of vesicles and organelles.  The MTs are essential to maintain 
the processes that extend from the cell and to provide polarity, distinguishing axonal 
and dendritic areas of the neuron, as well as providing tracks for kinesins and dynein to 
move along.  Neurofilaments (NFs) are necessary for resistance to stress and cell 
integrity and accumulate as the neuron matures (Levy and Holzbaur 2006). 
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In neurons anterograde movement, mainly by kinesins, transports newly synthesised 
synaptic vesicles and proteins, and organelles from the cell body along the axon to areas 
where they are needed, such as the synapse.  Retrograde transport, predominantly by 
dynein, is responsible for translocating cargo from the cell periphery and distal axon 
back to the cell centre, often for degradation and recycling. 
 
Retrograde signaling in neurons is very important and the dynein/dynactin complex 
plays a key role in transporting neurotrophic factors from the synapse to the cell body.  
Neurotrophins are a family of small molecules, such as nerve growth factor (NGF), 
brain derived neurotrophic factor (BDNF) and neurotrophin-4 (NF-4), that are secreted 
by target tissues, then bind to receptor tyrosine kinases (Trk receptors) on the surface of 
the neuron.  The neurotrophin/Trk receptor complex is then internalized and transported 
by dynein to the cell centre, beginning signalling cascades that regulate growth and 
survival (Levy and Holzbaur 2006).  When dynein function was blocked in cultured 
sensory neurons, the transport of activated Trk receptors was inhibited, demonstrating 
dynein is required (Heerssen, Pazyra et al. 2004). 
 
Degradation and recycling of misfolded or degraded proteins is particularly important 
in neurons as many neurodegenerative diseases have been linked to defective 
accumulation of protein aggregates.  Dynein has been established as the motor 
responsible for transporting proteins back to the cell body for lysosomal degradation or 
autophagy (Burkhardt, Echeverri et al. 1997; Levy and Holzbaur 2006). 
 
Because of the unique size and morphology of neurons, anterograde and retrograde 
transport systems are extremely important.  This makes neurons acutely sensitive to 
defects in, or disruption to, motor proteins, but particularly dynein as the predominant 
retrograde motor. 
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I.3  Dynein regulators and adaptors 
I.3.1  Dynactin 
 
Dynactin is a multisubunit complex, required for most, if not all, types of cytoplasmic 
dynein activity in eukaryotes (Schroer 2004).  It binds dynein and allows the motor to 
move long distances along the MTs. 
 
The dynactin complex consists of 11 different polypeptide subunits, some of which are 
present in more than one copy, resulting in a 1.2 MDa, 20S complex with more than 20 
polypeptide chains (Schroer 2004).  It consists of 2 morphologically distinct domains - 
a rod shaped domain that binds cargo, and an extended arm projection that binds MTs 
and dynein (Kim, Ling et al. 2007). 
 
The rod part of the dynactin molecule is a ~10x40 nm rod that resembles a short actin 
filament.  It is an octameric polymer of Arp1 - the actin related protein.  Arp1 filaments 
are very stable, short and of uniform length, meaning they are far less dynamic than 
conventional actin.  On one end of the Arp1 rod is the conventional actin capping 
protein, CapZ, and on the other end is another actin related protein, Arp11, and the 
dynactin subunit p62 (Schroer 2004). 
 
P62 primary sequence predicts a 53 kDa protein with a zinc-binding motif near the N-
terminus.  These motifs usually allow protein-protein interactions, so the N-terminus of 
p62 may be involved in binding to Arp1, Arp11, other dynactin subunits, or to other 
subcellular structures.  Its loss from the complex does not, however, affect the stability 
of dynactin (Lee, Kumar et al. 2001).  P62 and Arp11 associate with the two smallest 
dynactin subunits, p25 and p27, forming a heterotetrameric complex that is positioned 
at the end of the Arp1 rod, opposite CapZ (Schroer 2004). 
 
The components of the rod - Arp1, Arp11, p62, p25, p27, and CapZ are more highly 
conserved, in comparison to the arm projection of dynactin, and therefore may have 
important structural roles (Schroer 2004). 
 
The arm structure that projects from the Arp rod is both flexible and extendable and 
consists of 3 subunits: p150
Glued
, dynamitin (p50) and p24/22, with each dynactin 
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molecule containing 4 copies of dynamitin and 2 copies each of p150
Glued
 and p24/22 
(Schroer 2004).  Based on the sequences, all three polypeptides are predicted to form α-
helices with coiled-coils responsible for the interactions between the subunits. 
 
 
Figure 4.  Schematic showing structure of dynactin  
Schematic illustration of dynactin showing the arrangement and structure of the subunits in the complex.  
The structure and arrangement of dynactin have been inferred from EM studies and results combined 
from published results [From (Schroer 2004)]. 
 
Of all the dynactin subunits, p150
Glued
 is the largest and is thought to form an elongated 
dimer containing 2 central coiled-coils (~50 and ~20nm long respectively), with regions 
of unknown structure in between.  At the tip of the dynactin arm are 2 globular heads 
which contain a conserved CAP-Gly (cytoskeleton-associated protein, glycine rich) 
domain, which is at the far N-terminus (aa1-110) (Schroer 2004). 
 
The CAP-Gly motif is important for MT binding, which is necessary for dynactin to 
enhance the processivity of dynein.  This is demonstrated through the use of antibodies 
against the CAP-Gly domain which have been shown to abolish dynactin’s ability to 
increase the run length of dynein coated beads (King and Schroer 2000).  Truncation of 
p150 polypeptides have also been used to demonstrate that only fragments containing 
the CAP-Gly domain are able to bind to MTs (Culver-Hanlon, Lex et al. 2006).  
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Dynactin enhancement of dynein transport over long distances is necessary for proper 
neuronal function, indicating the importance of dynactin. 
 
Apart from MTs, the CAP-Gly domain also binds proteins such as the MT plus-end 
binding proteins EB1 and CLIP-170.  It is currently not known if p150
Glued
 binds both 
MTs and associated binding proteins at the same time, or only one at a time, which 
could suggest that the binding of associated proteins offers some form of regulation of 
dynactin.  This could be through either the promotion of enhancement of processivity, 
or binding of plus ends possibly to anchor the MTs (Schroer 2004). 
 
Another form of regulation may come from phosphorylation.  p150
Glued
 affinity for MTs 
is reduced by phosphorylation of p150
Glued
 at S19, suggesting that protein kinases can 
associate with and affect the activity of the CAP-Gly domain (Vaughan, Miura et al. 
2002). 
 
The N-terminal third of p150
Glued
, past the CAP-Gly motif (aa~220-550), is predicted to 
form an α-helical coiled-coil of approx. 50 nm length.  As the well defined arm of 
dynactin is known to be 24 nm in length, it suggests that the C-terminal half (aa~380-
550) of the arm is involved in the flexible shoulder located on top of the Arp rod 
(Schroer 2004). 
 
The middle part of p150
Glued
 is involved with binding dynein, as an antibody to the 
p150
Glued
 subunit blocks binding of dynein to dynactin, demonstrating that this region is 
important for binding (Waterman-Storer, Karki et al. 1997).  Also, a 123 aa fragment of 
DIC has been shown to bind a recombinant fragment of p150
Glued
 (aa 150-811) 
(Vaughan and Vallee 1995).  Vaughan et al found a serine residue (S84) in DIC that is 
thought to regulate, via phosphorylation, the ability of DIC to bind to p150
Glued
 
(Vaughan, Leszyk et al. 2001). 
 
p150
Glued
 has been shown to interact with members of the kinesin family - p150
Glued
 aa 
410-811 binds Eg5 and aa 600-811 binds kinesin II, suggesting p150
Glued
 may allow 
dynactin to interact with multiple MT based motors. 
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The C-terminal third of p150
Glued
 (aa ~900-1300) is less well defined than the N-
terminal region, but seems to allow a number of protein-protein interactions.  It is also 
proposed to play a role in linking the arm to the rod of dynactin, as it contains a 
conserved actin-binding motif which has been suggested to bind to the Arp1 filament.  
In addition, a mutation in Drosophila of the Glued gene product (which has sequence 
homology and functional similarities with p150
Glued
) in a region that corresponds with 
the C-terminal third of p150
Glued
 results in it not binding to the complex (McGrail, 
Gepner et al. 1995).  This suggests that the C-terminal region of p150
Glued
 is important 
for attachment of the arm projection to the Arp rod in dynactin. 
 
Also important for linking the arm to the Arp rod is dynamitin (p50).  In each dynactin 
molecule there are four subunits of dynamitin which are thought to tightly associate 
with each other and p24/22 via 3 coiled coils, forming the shoulder of dynactin.  P24/22 
is one of the smallest subunits of dynactin at only 21 kDa and is thought to be α-helical 
in structure (Karki, LaMonte et al. 1998).  The dynamitin-p24 complex interacts with 
p150
Glued
 and components of the Arp rod to hold the complex together (Maier, Godfrey 
et al. 2008).  Free dynamitin disrupts the structure, displacing p150
Glued
 and p24/22 
from dynactin and leaving the remaining structure non-functional (Echeverri, Paschal et 
al. 1996).  This demonstrates that dynamitin is essential in maintaining the structure of 
dynactin. 
 
There are a number of theories suggesting how dynactin might aid the function of 
dynein.  A number of studies have shown dynactin is involved in binding to some 
cargos, such as Arp1 binding to βIII, a Golgi specific spectrin isoform (Holleran, Ligon 
et al. 2001).  Bicaudal D (BICD) is a protein involved in Golgi-ER transport and has 
binding sites for both dynein and dynamitin.  Also, the BICD binding partner, Rab6 
binds to p150
Glued
 (Short, Preisinger et al. 2002) suggesting Rab6 may function as a 
tethering or specificity factor controlling the recruitment of dynactin to membranes.  
Rab7 and its effector protein Rab interacting lysosomal protein, RILP, recruit the 
dynein/dynactin complex to late endosomes and lysosomes, allowing their transport to 
the –end of MTs.  When this interaction is blocked, it results in late endosomes being 
transported towards the cell periphery by kinesin.  A direct interaction between 
dynein/dynactin and Rab7 or RILP has not been identified, but it suggests the existence 
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of a linker protein that mediates the association of the two complexes with each other 
(Jordens, Marsman et al. 2005). 
 
Another proposed function of dynactin is in increasing the processivity of dynein along 
MTs.  It has been shown that dynactin does increase the processivity of dynein, through 
increasing the run length of coated beads, but without affecting the velocity or ATPase 
kinetics of dynein (King and Schroer 2000).  The MT binding activity of dynactin is 
required for the increased processivity which indicates that dynactin aids processivity 
by providing an extra contact with MTs, reducing the risk of detachment from the MT 
(King and Schroer 2000). 
 
Further investigations into dynactin’s MT binding found that there are two MT binding 
domains in p150
Glued
- the CAP-Gly domain and a previously unknown basic region in 
the N-terminus.  This basic region binds to MTs, even in the absence of the CAP-Gly 
domain and is sufficient to increase processivity of dynein by demonstrating a “skating” 
behaviour along MTs (Culver-Hanlon, Lex et al. 2006).  This suggests that the two 
different MT binding domains in p150
Glued
 may play different roles in aiding dynein’s 
movement, with the basic domain maintaining contact between dynein, cargo and MTs, 
and the CAP-Gly domain allowing stable biding of MTs at the plus end to allow 
loading of cargo (Culver-Hanlon, Lex et al. 2006). 
 
A recent study by Ross et al (Ross, Wallace et al. 2006) has suggested that dynactin 
may play a role in the directionality of dynein.  The movement of GFP tagged 
dynein/dynactin complexes along MTs was tracked by single-molecule fluorescent 
microscopy.  The data suggests that dynactin may allow reversals in dynein’s 
movement as significant plus-end directed motion was detected in addition to the 
expected minus-end directed movement (Ross, Wallace et al. 2006).  However, a more 
recent study by Kardon et al, using yeast, suggests that although the dynein/dynactin 
complex is more processive than dynein alone, it does not increase the plus-end directed 
movement (Kardon, Reck-Peterson et al. 2009).  These differences may result from 
dynactin having different roles depending on its cargo, or simply from differences 
between mammalian and yeast dynactin. 
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I.3.2  Lis1, NudE and NudEL 
 
A number of proteins have been found to interact with dynein, and studies have shown 
them to be necessary for its proper functioning, suggesting them to be adaptors or 
regulators of dynein.  Lissencephaly 1 (Lis1) is a protein that directly interacts with 
dynein.  Mutations in the Lis1 gene are linked to the disease lissencephaly 1 which 
causes severe malformation of the cortex of the brain due to defective neuronal 
migration (Reiner, Carrozzo et al. 1993).  Nuclear distribution protein E (NudE) is 
involved in kinetochore function and along with the homologous protein NudE-like 
(NudEL) function with Lis1, interacting with dynein. 
 
Studies have shown that Lis1, NudE and NudEL are extremely important for a number 
of dynein functions, including organelle transport, kinetochore activity, and nuclear and 
spindle positioning (Liang, Yu et al. 2004).  Loss of function mutations in all three 
proteins result in very similar phenotypes affecting dynein function, which suggests 
they act as important co-factors.  They directly interact with dynein and have been 
shown to be involved in dynein mediated transport of kinetochore proteins (Howell, 
McEwen et al. 2001).  However, their exact mechanisms are not currently well 
understood.   
 
NudE and NudEL mutants defective for Lis1 or DHC binding cause phenotypes similar 
to those seen from dynein disruption, such as Golgi fragmentation and reduced vesicle 
trafficking.  Studies have also shown that in the absence of NudE/NudEL, dynein is still 
able to bind to MTs and cargo, but movement is impaired (Liang, Yu et al. 2004), 
suggesting that the interaction of Lis1, NudE, NudEL with dynein is important in 
regulating a number of dynein functions.   
 
Complete inhibition of NudE and NudEL function prevents dynein, dynactin and Lis1 
from localising to kinetochores, which leads to cell arrest at metaphase and 
misorientation of the kinetochores (Stehman, Chen et al. 2007).  This suggests that 
NudE and NudEL are important for recruiting dynein/dynactin and Lis1 to 
kinetochores. 
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In neural progenitor cells, Lis1, NudE and dynein are responsible for the proper 
positioning of nuclei and spindles for cell division.  The resulting neurons require Lis1, 
NudEL and dynein for the movement of the centrosome and nucleus during migration 
[Refs in (Kardon and Vale 2009)]. 
 
A unique feature of Lis1 is that it binds directly to the motor domain of dynein.  Lis1 
comprises an N-terminal coiled-coil attached to seven WD40 repeats (40 amino acids 
with a C-terminal Trp-Asp dipeptide), which dimerises at the coiled-coil.  The WD40 
repeat binds to the AAA1 domain of the dynein motor.  Lis1 interacts with both NudE 
and NudEL, but exact sites of interaction have yet to be identified (Sasaki, Shionoya et 
al. 2000).  
 
 
Figure 5.  Schematic of cytoplasmic dynein showing sites of interaction with regulators and 
adaptors.     The dimerised dynein heavy chain is shown in blue.  The sites of interaction with the dynein 
regulators dynactin, Lis1, NudE and NudEL are shown, as well as other proteins proposed to regulate and 
adapt dynein function  [From (Kardon and Vale 2009)]. 
 
NudE and NudEL are highly homologous, both containing an N-terminal coiled-coil, 
which is important for dimerisation, as well as Lis1 binding.  The C-terminus is 
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unstructured, but binds to the AAA1 domain of dynein.  This region also interacts with 
the light chain, LC8 and DIC (Sasaki, Shionoya et al. 2000), as well as kinetochore 
proteins, centromere protein F (CENPF) and ZW10.  ZW10 also interacts with 
dynamitin in dynactin (Starr, Williams et al. 1998).  Lis1 has been shown to be 
necessary for dynein to localise to MT plus ends (Markus, Punch et al. 2009).   
 
Recent studies have indicated that Lis1 may be involved in regulating the ATPase 
activity of dynein, however, there are conflicting results from the different studies.  
Mesngon et al (Mesngon, Tarricone et al. 2006), showed that in using native brain 
dynein and recombinant Lis1, the two proteins bind and Lis1 significantly increases the 
MT stimulated ATPase activity of dynein.  Their data showed that Lis1 must be 
dimerised for this ATPase regulation to occur, as a C-terminal fragment lacking the 
dimerisation domain, but retaining the dynein interaction site was unable to alter 
ATPase activity. 
 
However, the Hirotsune group showed that Lis1 suppressed the motility of native 
dynein (purified from porcine brain tissue) along MTs and it is NudEL that releases this 
effect by blocking Lis1 suppression.  Lis1 increased ATPase activity at concentrations 
that inhibit motility, suggesting Lis1 separates the mechanical-chemical coupling of 
dynein.  NudEL reduced by ~60% the MT stimulated ATPase activity, which is in 
keeping with data showing NudEL is involved in dissociating dynein from MTs 
(Yamada, Toba et al. 2008). 
 
It appears that Lis1, in conjunction with NudE and/or NudEL, is involved in regulating 
ATPase function in the dynein motor, but further work is needed to determine the exact 
mechanism of this regulation. 
 
It has been proposed that Lis1 and NudE or NudEL complexes may affect the 
conformation of dynein.  As Lis1/NudE and Lis1/NudEL are dimers, they could 
possibly bridge across two AAA1 domains, bringing them into closer proximity.  
Another possibility is that the motor and tail domains of dynein could be brought 
together into a folded conformation, as the C-terminus of NudE and NudEL is able to 
bind LC8 and Lis1 binds the motor (Kardon and Vale 2009), although if this occurs, 
and how it might affect regulation remains to be determined. 
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I.4  Dynein Cargos 
 
As the main retrograde motor in cells, cytoplasmic dynein is responsible for the 
transport and localisation of an enormous range of cargos.  These include large 
membrane organelles such as the Golgi, mitochondria and nuclei; small vesicles and 
tubular intermediates in the endocytic and secretory pathways; and cytoskeletal 
filaments such as MTs and actin filaments. 
 
I.4.1  Golgi  
 
The Golgi apparatus consists of a network of flattened membrane cisternae that are 
interconnected and associated with tubules and vesicles.  The Golgi is responsible for 
the post-translational modifications of proteins and macromolecules transported from 
the rER which are then packaged for transport to the plasma membrane (e.g. for 
exocytosis) or the secretory or endocytic pathways. 
 
The Golgi maintains a perinuclear position, often close to the MT organising centre 
(MTOC).  MTs are known to have an important role in maintaining the location and 
integrity of the Golgi as disruption of MTs using depolymerising drugs causes the Golgi 
to fragment and disperse throughout the cell.  Upon removal of the depolymerising 
drug, the MTs are able to repolymerise and the Golgi fragments move along the MTs 
towards the centrosome to re-form the membrane network.   
 
Dynein was proposed to be the MT motor responsible for maintaining the structure of 
Golgi and repositioning it after disruption, and a number of studies have confirmed this.  
Burkhardt et al overexpressed the dynactin subunit, dynamitin, which caused 
fragmentation of the Golgi, despite the MT complex remaining intact.  Also, the 
microinjection of function blocking DIC antibodies resulted in the same Golgi 
fragmentation and dispersal (Burkhardt, Echeverri et al. 1997).  A similar phenotype 
was also identified in blastocysts cultured from DHC knockout mice (Harada, Takei et 
al. 1998), confirming that dynein is the motor responsible for maintaining integrity and 
localisation of Golgi. 
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There appear to be a number of factors that play a role in the recruitment of 
dynein/dynactin to Golgi membranes.  Arp1 of dynactin has been shown to directly 
bind a Golgi specific isoform of spectrin, βIII (Holleran, Ligon et al. 2001).  Spectrins 
are cytoskeletal proteins that provide structure and integrity to many membranes.  There 
are two Arp1 binding sites in βIII spectrin, one of which overlaps with the well 
conserved actin binding site (Holleran, Ligon et al. 2001).  The interaction between βIII 
spectrin and Arp1 provides a direct link between the dynein/dynactin complex and its 
Golgi cargo. 
 
I.4.2  Mitochondria 
 
The correct distribution of mitochondria throughout a cell is essential for proper cell 
functioning and survival.  Mitochondria have a number of crucial roles in the cell- 
energy production, cell signalling, calcium homeostasis and apoptosis.  Different types 
of cells have different requirements, and thus the distribution of mitochondria is 
specific to the energy needs of that cell.  For example, in neurons, high energy demands 
at the synapse mean more mitochondria are required at this location (Hollenbeck and 
Saxton 2005). 
 
Dynein and kinesin motors play important roles in the transport of mitochondria and are 
essential for proper distribution throughout the cell.  Mitochondria are synthesised in 
the cell body and must be transported to the location of energy requirement.  In neurons 
they need to be distributed along the axon, which occurs through a combination of 
transport, at velocities of 0.3-2.0µm.s
-1
, and stopping as over half of mitochondria are 
stationery [Refs in (Miller and Sheetz 2004)].  Disruption of axonal transport leads to 
non-uniform distribution of organelles, including mitochondria, along the axon. 
 
Mitochondrial potential drives the production of ATP.  The potential is generated by 
oxidative phosphorylation through the electron transport chain (ETC) and varies in 
response to changes in metabolic demand.  Using the potential-sensitive dye JC-1 
Miller and Sheetz have shown that ~90% of mitochondria with a high potential move 
anterogradely towards the growth cone in neurons, while ~80% of low potential 
mitochondria move retrogradely towards the cell body (Miller and Sheetz 2004).  
Depolarised mitochondria are retrogradely transported to lysosomes to be recycled by 
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autophagy.  Aged mitochondria become, on average, more depolarised and so 
retrograde transport by dynein is essential to ensure that non-functioning mitochondria 
are removed from cells. 
 
Tctex-1 can interact with the voltage dependent anion-selective channel (VDAC1) in 
the mitochondrial outer membrane (MOM).  This interaction could regulate the binding 
of dynein when the mitochondrial membrane potential is decreased, and may contribute 
to increased retrograde transport (Boldogh and Pon 2007). 
 
Mitochondria are highly dynamic organelles that constantly alter their morphology 
using fission and fusion in response to a range of signals (Santel and Frank 2008).  The 
main factors required for fusion of mammalian mitochondria are the large 
mitochondrial GTPases, mitofusin (MFN) 1 and 2, and optic atrophy 1 (OPA1).  The 
protein mainly responsible for fission is dynamin related protein 1 (DRP1), also a large 
GTPase (Santel and Frank 2008). 
 
MFN 1 and 2 localise to the mitochondrial outer membrane, while OPA1 is located at 
the inner membrane, suggesting that MFN1 and 2 are involved with outer membrane 
fusion and OPA1 is involved with fusion of the inner membrane.  MFN1 and 2 contain 
coiled-coil regions that project from the outer membrane allowing tethering of two 
mitochondria together (Suen, Norris et al. 2008) ultimately resulting in fusion. 
 
Mitochondrial fission consists of a number of steps.  Drp1 is recruited to the outer 
membrane, where multimerisation of the protein occurs, which finally results in fission 
of the membrane bilayers.  A neuronal isoform, Drp1p, is important for the correct 
distribution of mitochondria to the synapse.  In HeLa cells it has been shown that 
disruption of dynein via DIC, or dynactin through dynamitin, results in the 
repositioning of Drp1 from the mitochondria to other cytoplasmic membranes.  Also 
seen is the transport of mitochondria from the cell cortex to a perinuclear region 
(Varadi, Johnson-Cadwell et al. 2004).  This suggests that dynein might contribute to 
the targeting of Drp1 to mitochondria in addition to its more established roles (Boldogh 
and Pon 2007). 
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 I.4.3  Endosomes 
 
Endosomes are transport vesicles formed during the process of endocytosis.  This is the 
uptake of material into a cell by invagination of the plasma membrane and its 
internalisation in a membrane bound vesicle (Alberts, Johnson et al. 2002). 
 
Mammalian cells contain many complex intracellular structures, which means diffusion 
can only occur at slow rates.  Cells have therefore developed active intracellular 
transport systems to move and target macromolecules to their correct destinations.  This 
can either result in transport to the lysosomes for degradation of the contents of the 
vesicle, or recycling of the vesicle back to the cell membrane. 
 
Endocytosis encompasses various forms of uptake of extracellular material by cells, 
including phagocytosis, the uptake of large particles, usually carried out by specialist 
cells (such as macrophages), and pinocytosis, the internalisation of fluids.  It also 
includes uptake into membrane pits which can either be coated, as with clathrin-
dependent and caveolin-dependent endocytosis, or uncoated, as with clathrin-
independent and caveolin-independent endocytosis (Mukherjee, Ghosh et al. 1997). 
 
Clathrin and caveolin are coat proteins that cause curvature of the membrane to form 
vesicles (Parkar, Akpa et al. 2009).  Clathrin forms the structural backbone of clathrin-
coated pits (CCPs), but adaptor proteins (APs) are required that can attach to both the 
pit and the cargo.  It is currently unclear as to whether existing vesicles trap and 
internalise cargo, or the presence of cargo causes vesicle formation.  In clathrin-
dependent endocytosis it appears to depend on the cargo.  EGF receptor stimulates the 
formation of new CCPs, but transferrin receptor (TfR) stabilises existing CCPs and is 
then internalised into them (Benmerah and Lamaze 2007).  Caveolae are mainly pre-
existing vesicles, but need to be stimulated for internalisation of cargo to occur.  There 
are a number of different isoforms of caveolin that are important for the proper 
formation of caveolae. 
 
Once the pits have formed, dynamin, a large GTPase, is involved in scission of the pits 
into vesicles.  Once the vesicles are released from the membrane, the clathrin coat is 
released and recycled back to the plasma membrane.  Caveolae do not strip caveolin 
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upon internalisation, but fuse with existing endosomes and release their contents, before 
recycling back to the cell surface.   
 
I.4.3.1  Receptor mediated endocytosis 
 
Receptors that use existing CCPs are thought to internalise by constitutive endocytosis, 
regardless of whether they are bound to their ligands.  However, in receptor-mediated 
endocytosis, the ligand binding to its receptor stimulates the formation of the clathrin-
coated vesicle and the internalisation of the ligand-receptor complex (Benmerah and 
Lamaze 2007). 
 
A large range of receptors are internalised in clathrin-coated vesicles (CCVs), for 
example, epidermal growth factor receptor (EGFR), transferrin receptor (TfR), low-
density lipoprotein receptor (LDL-R), β2 adrenergic receptors and insulin receptor.  By 
controlling cell-surface receptors such as these, CCPs can regulate cell signalling 
(Parkar, Akpa et al. 2009).  CCVs also play a role in protein sorting and are found at the 
trans-Golgi network (TGN). 
 
Once the CCV is internalised and pinched off from the membrane by dynamin, the 
clathrin coat recycles back to the plasma membrane and the CCVs fuse to form early 
endosomes.  Fusion of these early endosomes gives rise to multi-vesicular bodies 
(MVBs), and it is from these that proteins either recycle back to the cell surface, or 
continue in the degradative pathway to the lysosomes. 
 
Rab proteins are involved in regulating fusion and fission of vesicles and are involved 
in sorting cargo in vesicles by creating subdomains (Jordens, Marsman et al. 2005).  
Rab5 has been shown to be present on early endosomes and through its interaction with 
its effector protein, early endosome antigen (EEA1), it is involved in endosomal fusion 
(Woodman 2000).  Rab5 is also important for the transport of early endosomes as it 
interacts with DIC and may be involved in tethering early endosomes to the dynein 
complex for transport.  Once vesicular sorting has occurred, early endosomes or MVBs 
fuse together to form late endosomes.  This is coupled to the loss of Rab5 and the gain 
of Rab7.  Rab7 and its effector protein, Rab7-interacting lysosomal protein (RILP), 
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recruit the dynein/dynactin complex to late endosomes for transport and fusion to the 
lysosomes for degradation (Jordens, Marsman et al. 2005). 
 
I.4.3.1.1  EGF/EGFR endocytosis 
 
The epidermal growth factor (EGF) receptor (EGFR) is a widely expressed 
transmembrane receptor tyrosine kinase.  It is activated via binding of a number of 
ligands, such as EGF, which promotes receptor dimerisation and autophosphorylation.  
EGF receptor-ligand binding can activate signalling of a wide variety of pathways that 
can lead to cell proliferation, differentiation, motility or survival, depending on the 
ligand and cell involved. 
 
Once activated, EGFR is endocytosed into clathrin-coated pits.  EGFRs remain active 
after internalisation and remains so until they reach the lysosome for degradation.  
Transport to the lysosomes is dynein dependent as disruption of the dynein complex in 
HeLa cells inhibits retrograde movement of EGF-positive endosomes (Driskell, 
Mironov et al. 2007).  Delay in reaching the lysosomes for degradation has been shown 
to result in prolonged EGFR signalling, that in turn leads to sustained activation of 
downstream targets (Taub, Teis et al. 2007). 
 
I.5  Dynein mutations 
 
The importance of dynein in cellular function is well documented, but its exact 
mechanism of function and interaction with other proteins is not fully understood.  To 
provide a better understanding of the functional interplay between dynein and cellular 
mechanisms in organisms, mutagenesis of dynein in model organisms has provided 
invaluable information about the downstream effects of disrupted dynein.  Many of 
these mutations in animal models have resulted in phenotypes that mimic, or are similar 
to human diseases, providing insight into the importance of the protein and the many 
cellular functions it participates in.  This can also provide information about possible 
mechanisms of disease that may involve dynein. 
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I.5.1  Legs at odd angles (Loa) and Cramping 1 (Cra1) 
 
Hafezparast et al (2003) described two new DHC mutations in mice that help provide 
further information about the functioning of dynein, as well as how defects in dynein 
can lead to phenotypes that are similar to human disease. 
 
Two independent ENU mutagenesis programmes resulted in two mouse mutants that 
exhibited a similar, unusual twisting and clenching of the hindlimbs when suspended by 
the tail.  Due to their phenotypes they were named Legs at odd angles (Loa) and 
Cramping1 (Cra1).  Both mutations are autosomal dominant traits that in heterozygotes 
cause progressive loss of muscle tone and locomotor ability, but without significant 
reduction in lifespan.  The homozygotes are much more severely affected with inability 
to move or feed properly and die within 24 hours of birth (Hafezparast, Klocke et al. 
2003). 
 
Both mutations were confirmed as being due to single amino acid substitutions in 
Dync1h1.  Loa results from a T-A transversion in Dync1h1 changing a phenylalanine to 
tyrosine at residue 580.  Cra1 is due to a change of A-G in Dync1h1 resulting in 
tyrosine to cysteine at residue 1055.  The two mutations were found to be allelic, as 
when crossed together, they produced compound heterozygotes with the same 
phenotypes as the homozygotes and all died within 48 hours of birth (Hafezparast, 
Klocke et al. 2003).   
 
The Loa mutation occurs within the highly conserved region thought to be the binding 
site for Dync1i1 chains and the site for homodimerisation, and the Cra1 mutation is in a 
potential area of homodimerisation. 
 
No differences were identified in the amounts of DHC and DIC protein between Loa 
and Cra1 homozygous, heterozygous and WT mice, and the localisation of DHC and 
DIC was not affected by the mutations.  This suggests that the phenotypes caused by 
the Loa and Cra1 mutations are not due to changes in the amount of protein or its 
location in the cell (Hafezparast, Klocke et al. 2003). 
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As the hindlimb clenching is typical of a neuromuscular defect, and progressive motor 
impairment is seen, the motor neurons were checked.  The number of α-motor neurons 
(the large calibre neurons that innervate muscle), in the spinal cord anterior horn were 
compared between heterozygote and wildtype littermates at 3 months and then at 19 
months in Loa and 16 months in Cra1.  A significant decrease was detected in both sets 
of mice over these timeframes (Hafezparast, Klocke et al. 2003). 
 
The anterior horn cells (AHCs) of Loa and Cra1 homozygous embryos, at embryonic 
age E18.5, and wildtype littermates were compared, with the Loa/Loa embryos showing 
50% fewer AHCs compared to WT, while the Cra1/Cra1 embryos showed an 80% 
decrease.  The AHCs in these homozygous mutants also had increased rates of 
apoptosis and the surviving neurons contained intracellular inclusions.  These inclusions 
were found to contain ubiquitin, SOD1, CDK5 and NFs, similar to the inclusions that 
are characteristic of human amyotrophic lateral sclerosis (ALS) (Hafezparast, Klocke et 
al. 2003). 
 
Dupuis et al (Dupuis, Fergani et al. 2009) also investigated neuronal degeneration in 
Cra1/+ mice to fully characterise the motor defect.  Motor neurons in adult spinal cord 
anterior horns were counted to establish cell loss, however, none was established, even 
in aged mice.  Corticalspinal motor neurons from 14 month old Cra1/+ mice were also 
checked and did not show any difference in number compared to WT littermates.  These 
data suggest that Cra1/+ mice do not in fact display typical motor neuron disease. 
 
The hindlimb grip strength in Loa/+ has been shown to be reduced by 52%, but 
forelimb grip strength is unaffected, compared to WT littermates (Chen, Levedakou et 
al. 2007).  In agreement with this, cervical dorsal root ganglion (DRG) neurons are not 
affected, but lumbar DRG neurons are reduced by 42% in Loa/+ compared to WT.  
Muscle spindles are central to the proprioceptive sensory system, allowing perception of 
the positioning of limbs.  In 13 week old Loa/+ mice, muscle spindles were seen to be 
reduced by 86% in the hindlimbs compared to WT.  Together these data suggest that 
Loa/+ mice exhibit a proprioceptive sensory defect (Chen, Levedakou et al. 2007). 
 
To determine the exact timing of the motor axon degeneration identified by Hafezparast 
et al (Hafezparast, Klocke et al. 2003), lumbar motor roots in young Loa/+ mice were 
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examined (from 1.5 months – 22 months).  At 1.5 months, Loa/+ mice exhibited loss of 
motor axons compared to WT, however, no reduction in α-motor axons (>3.5 µm 
diameter) was observed, but a 55% loss of γ-motor neurons (which innervate muscle 
spindles) was identified (Ilieva, Yamanaka et al. 2008).  No further loss was identified 
up to 22 months of age. 
 
Despite α-motor neuron loss not being detected in older mice in this study (Ilieva, 
Yamanaka et al. 2008), significant loss of sensory neurons was identified in 1.5 month 
old mice, continuing through to 22 month old mice.  No effect on nociception was 
identified in Loa/+ mice, so the significant loss of sensory neurons suggests that 
proprioception may be affected.  To confirm this, proprioceptive axonal function was 
tested by examining the stretch reflex in adult Loa/+ mice.  The expected H wave was 
entirely absent from all Loa/+ mice tested, but present in WT, confirming the presence 
of a defect in proprioception in Loa/+ mice. 
 
In Loa mice, the effect of the mutation on Golgi was investigated.  Normal positioning 
and morphology of Golgi was identified in mouse embryonic fibroblasts (MEFs), 
however, the ability of dynein to re-position Golgi after disruption was impaired.  MTs 
were depolymerised with the drug, nocodazole, fragmenting the Golgi throughout the 
cell.  Once the nocodazole was removed, the MTs repolymerised and in WT cells the 
Golgi was reassembled into its perinuclear position by dynein.  However, in Loa/Loa 
cells this was significantly impaired.  The authors suggest that normal Golgi positioning 
and morphology, but impaired reassembly after disruption, shows that the Loa mutation 
reduces dynein function only during cellular stress (Hafezparast, Klocke et al. 2003). 
 
Fragmented Golgi complex, similar to that seen in nocodazole treated cells, is a feature 
of both human ALS and the mutant SOD1 transgenic mice that model ALS.  Disrupted 
Golgi is also seen in embryos from dynein knockout mice (Harada, Takei et al. 1998). 
 
Dynein has a number of roles that are specific to neurons, including neuronal migration 
and axonal transport of organelles.  The effects of the Loa mutation on these roles were 
investigated by analysing the formation of cranial and spinal nerves in E10.5 Loa/Loa 
and WT littermates.  Although there was no difference in motor neuron differentiation 
in the neural tube, a difference was seen in the migration of motor neuron cell bodies 
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from the face to hindbrain in Loa homozygous embryos.  This is similar to the facial 
weakness caused by impaired lower motor neurons in the brainstem of spinal bulbar 
muscular atrophy (SBMA) patients, and some bulbar subtypes of ALS (Hafezparast, 
Klocke et al. 2003). 
 
Investigations into retrograde axonal transport using a fluorescent fragment of the 
tetanus toxin (TeNT Hc) showed that although retrograde transport was not abolished in 
Loa/Loa neurons, there was a significant reduction in the frequency of high speed 
carriers and an increase in stationary pauses.  This suggests that the Loa mutation 
impairs dynein’s ability to maintain fast retrograde transport (Hafezparast, Klocke et al. 
2003). 
 
The range of different studies carried out on Loa and Cra1 mice suggests that the 
similar phenotypes observed in both are due to sensory defects, with accompanying 
motor defects that vary in severity and require further investigation. 
  
I.5.2  Sprawling mouse (Swl) 
 
The sprawling mouse (Swl) is a radiation induced, autosomal dominant mutation, first 
identified due to its hindlimb clenching when suspended by the tail, as well as an 
unsteady, jerky gait (Duchen 1974).  It has been shown to be caused by a 9 base pair 
deletion in Dync1h1 that changes 4 residues at position 1040-1043 to a single alanine 
(Chen, Levedakou et al. 2007). 
 
The hindlimb clenching is similar to that seen in Loa and Cra1 heterozygotes, but 
Swl/+ mice also develop an abnormal gait, characterised by a jerky, wobbly movement.  
When stationary the hindlimbs are splayed outwards and forwards, and the hindlimbs 
have reduced grip strength.  The Swl/+ mice have a normal lifespan and no obvious 
progression of the phenotype with age has been identified (Chen, Levedakou et al. 
2007).  
 
Due to the hindlimb clenching, and abnormal gait phenotypes, the limbs of Swl/+ mice 
are clearly affected.  Motor function and grip strength were investigated using motor 
nerve conductance velocity (NCV) tests on Swl/+ and WT littermates, which showed  
  
Loa Cra1 
Autosomal dominant mutation – due to single amino acid substitution 
in Dync1h1. 
Autosomal dominant mutation – due to single amino acid substitution 
in Dync1h1. 
Progressive loss of locomotor ability, but no significant reduction in 
lifespan. 
V. mild effect on gait, no significant reduction in lifespan. 
Mutation located in region of DHC involved in DLIC binding and 
homodimerisation. 
Mutation located in region of DHC thought to be involved in 
homodimerisation. 
Significant loss of anterior horn cells (AHCs) in Arl/+ compared to 
WT.  Loss of γ-motor neurons, not α-MNs, identified by Ilieva et al. 
Conflicting data – reduction in AHCs seen by Hafezparast et al, but 
none seen by Dupuis et al. 
Reduction in lumbar dorsal root neurons Loss of neurons in dorsal root 
Phenotype suggested to be due to proprioceptive defects with 
accompanying motor defects 
Phenotype thought to be due to proprioceptive sensory defects, with 
lack of motor defects. 
Rescue of SOD1
G93A
 phenotype identified Rescue of SOD1
G93A
 phenotype identified, although less significant 
than with Loa. 
 
Table 1.  Comparisons between Loa and Cra1 mice and phenotypes. 
Table comparing major features of the Loa and Cra1 mice as detailed in studies conducted by Hafezparast et al., Ilieva et al. and Dupuis et al. (Hafezparast, Klocke et al. 
2003; Ilieva, Yamanaka et al. 2008; Dupuis, Fergani et al. 2009) 
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forelimb grip strength was unaffected, but a 50% decrease was identified in hindlimbs.  
Normal peripheral motor nerve function was detected through measuring the velocity 
and amplification of the compound muscle action potential (M wave).  The morphology 
and number of α-motor neurons was unaffected, suggesting the reduced hindlimb grip 
strength is not due to defects in the anterior horn of the lumbar spinal cord (Chen, 
Levedakou et al. 2007). 
 
Previously, Swl mice have been characterised as having thin peripheral nerves and 
sensory roots, a reduced number of DRG neurons, small dorsal columns of the spinal 
cord, and a marked reduction in the number of sensory neurons (Duchen 1974).  To 
determine whether specific subpopulations of sensory ganglion neurons are affected, 
tail flick tests were used to investigate nociceptive sensory function.  These showed that 
nociception was unaffected in Swl/+ mice compared to WT, and this is backed up by 
the lack of limb amputations seen in Swl/+ mice.  Sensory NCV, measured to assess 
sensory nerve function, showed no difference between Swl/+ and WT, however, the 
amplitude of the sensory nerve action potential was reduced by 32% (Chen, Levedakou 
et al. 2007).  These data suggest that the Swl mutation does not affect the nociceptive or 
motor function of these mice, but rather some other sensory aspect. 
 
Consequently, the proprioceptive function was assessed using the H reflex in tibial 
nerves.  The H reflex measures the afferent Ia fibres and the efferent α-motor fibres 
across the reflex arc, which provides a measure of proprioceptive function.  The H 
reflex was completely absent from the hindlimbs of all the Swl/+ mice tested, but 
present in all WT mice.  This together with normal motor nerve function suggests that 
the proprioceptive function of the Swl sensory system is affected.  In keeping with this 
data, the number of proprioceptive sensory receptors was significantly reduced in Swl/+ 
compared to WT (Chen, Levedakou et al. 2007). 
 
The neuron loss in DRGs was further investigated and the reduction was found to be 
greater in lumbar segments than cervical segments in Swl/+.  This is consistent with the 
hindlimbs being much more affected than the forelimbs in Swl/+ mice.  In these 
sections the number of proprioceptive sensory neurons is greatly reduced in Swl, much 
more so than for nociceptive sensory neurons.  These data suggest that the 
subpopulation of proprioceptive sensory neurons is much more severely affected than 
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the subpopulation of nociceptive sensory neurons in Swl/+ lumbar DRGs (Chen, 
Levedakou et al. 2007). 
 
Degeneration of muscle spindles during late embryonic development, between E15.5 
and P0.5, was identified and found to accompany the loss of lumbar proprioceptive 
neurons in Swl/+ mice (Chen, Levedakou et al. 2007). 
 
Taken together, this data suggests that Swl is due to an early onset proprioceptive 
sensory defect and it is this, rather than motor neuron loss, that is probably the cause of 
the phenotype seen.  This indicates that a mutation in DHC can lead to sensory neuron 
defects.  Proprioceptive sensory neurons are a subpopulation of DRG neurons 
characterised by medium and large soma areas, and like α-motor neurons, they require a 
large supply of energy and significant trafficking; this may cause them to be 
particularly vulnerable to vesicular and axonal transport defects, particularly as 
previous studies have shown large motor and sensory neurons are more vulnerable to 
diseased conditions than small sized neurons (McIlwain 1991).  As dynein transports 
vesicles and organelles from nerve terminals to cell bodies, neurons with longer axons 
are more likely to be affected by Swl mutation which may explain why hindlimbs, but 
not forelimbs are affected. 
 
I.5.3  Motor neuron disease and SOD1 
 
Motor neuron diseases (MND) encompass several adult and juvenile onset 
neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), spinal 
muscular atrophy (SMA), spinal bulbar muscular atrophy (SBMA) and hereditary 
spastic paraplegias (HSP). 
 
ALS is the most common adult-onset motor neuron disease and leads to selective 
dysfunction and death of neurons in the cortex, brainstem, and spinal cord, with the 
large diameter α-motor neurons in the spinal anterior horns mainly targeted.   It is 
progressive and terminal, causing muscle weakness, atrophy and spasticity, leading to 
eventual paralysis and death within 2-5 years of onset (Julien and Kriz 2006).  ALS 
generally occurs in middle to late age with a lifetime risk of ~1 in 2000 (Bruijn, Miller 
et al. 2004).   
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There are no effective treatments to delay or cure the disease and the causes for the 
majority of cases are unknown.  Clinically they can be highly variable, suggesting that 
many factors may contribute to the disease mechanism.  These are classed as sporadic 
ALS (SALS) and account for ~90% of cases.  The remaining 10% of ALS cases are 
familial (FALS), and of these, 20-25% are mapped to the Cu/Zn-SOD1 gene on 
chromosome 21.  More than 100 different mutations have been identified (Rosen, 
Siddique et al. 1993; Gaudette, Hirano et al. 2000).   
 
Superoxide dismutase 1 (SOD1) is a ubiquitously expressed cytosolic metalloenzyme 
that catalyses the formation of hydrogen peroxide and oxygen via dismutation of 
superoxide anions.  It is thought that this action protects against cellular damage 
induced by oxygen radicals (Shaw 2001). 
 
Transgenic mice expressing various forms of mutant SOD1 have been generated and 
mice over-expressing mutant SOD1 develop ALS; with SOD1
G93A
, SOD1
G37R
 and 
SOD1
G85R
 the most studied forms, developing many pathological phenotypes seen in 
human ALS (Turner and Talbot 2008). 
 
The main characteristics of the SOD1
G93A
 mice are hindlimb tremor and weakness 
which develop at around 3 months.  This progresses to paralysis and death after 
approximately 4 months.  SOD1
G37R
 and SOD1
G85R
 show similar phenotypes, but they 
present at later timepoints, with disease onset visible at 4-6 months and 8-14 months 
respectively [Reviewed in (Turner and Talbot 2008)]. 
 
The mutations in SOD1 are not due to loss of function, as SOD1 knockout mice do not 
develop motor neuron disease (Reaume, Elliott et al. 1996).  Also, expression of a 
dismutase inactive mutant did not affect onset of disease or survival, and increased 
levels of WT-SOD1 had no effect, or even accelerated the disease (Bruijn, Houseweart 
et al. 1998; Jaarsma, Rognoni et al. 2001).  This suggests the SOD1 mutations cause a 
toxic gain of function, and as a common feature of affected mice is the presence of 
large aggregates and cellular inclusions, it is most likely from the formation of 
aggregates and misfolded protein.  However, the exact mechanism through which 
SOD1 results in motor neuron degeneration is currently unclear. 
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To better understand how mutant SOD1 interacts with motor neurons to induce 
degeneration, the pathology of neuronal cells in SOD1 mice was investigated.  A 
common feature among mutant SOD1 mice is the presence of neuronal and astrocytic 
inclusions and aggregates highly immunoreactive for SOD1.  These inclusions are 
similar to SOD1-containing aggregates seen in some human sporadic and familial ALS 
cases (Bruijn, Houseweart et al. 1998). 
 
Defects in axonal transport have been identified in SOD1 mice, with a slowing in 
tubulin and NF transport occurring just before disease onset and one of the earliest 
pathologies detected (Williamson and Cleveland 1999). 
 
SOD1 is ubiquitously expressed, but it has been shown that motor neurons from mutant 
SOD1 mice can avoid degeneration if some surrounding non-neuronal cells are 
unaffected.  Conversely, affected non-neuronal cells expressing mutant SOD1 are able 
to translate the damage to motor neurons that they surround, suggesting non-cell 
autonomous excitotoxicity is involved (Ilieva, Yamanaka et al. 2008). 
 
I.5.4  Dynein mutations and SOD1 
 
Although mutations in dynein have not been found in ALS patients (Ahmad-Annuar, 
Shah et al. 2003; Shah, Ahmad-Annuar et al. 2006), mutations in dynactin have been 
identified in patients with slow progressing forms of ALS (Puls, Jonnakuty et al. 2003), 
highlighting the relevance of mutations in the dynein complex in ALS.  As dynein is the 
major retrograde motor in neurons and Loa and Cra1 have been shown to cause 
degeneration of motor neurons, and with motor neuron degeneration and axonal 
transport defects seen in SOD1 mice, a possible link between dynein and mutant SOD1 
was investigated. 
 
Loa mice were crossed with SOD1
G93A
 mice to investigate whether the interaction 
between the dynein mutation and mutant SOD1 had any effect on disease progression 
and lifespan in double heterozygote (Loa/SOD1
G93A
) mice (Kieran, Hafezparast et al. 
2005).  Surprisingly, the double heterozygotes showed an improvement over SOD1
G93A
 
littermates, showing that Loa rescues the SOD1 phenotype. 
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As previously mentioned, Loa/+ mice have a normal lifespan (Hafezparast, Klocke et 
al. 2003), while SOD1
G93A
 mice have a reduced lifespan of only 125 days.  The 
Loa/SOD1
G93A
 mice showed a significant increase in their lifespan of 28% to 160 days, 
also with significant delay in the onset of the disease (Kieran, Hafezparast et al. 2005). 
 
Axonal transport defects in E13 motor neurons were completely rescued in 
Loa/SOD1
G93A
 mice compared to SOD1 mice.  There was also a significant increase in 
motor neuron survival in the spinal cord of Loa/SOD1
G93A
 adult mice (Kieran, 
Hafezparast et al. 2005).  
 
The results suggest that defects in axonal transport contribute to motor neuron 
degeneration in SOD1
G93A
 mice and that rescuing these defects can have a favourable 
effect on both disease progression and lifespan (Kieran, Hafezparast et al. 2005). 
 
To determine if the rescue of the phenotype in SOD1 mice is confined to the Loa 
mutation, or whether other dynein mutations could have the same effect, Cra1 mice 
were crossed with SOD1
G93A
 mice.  The resulting double heterozygote 
(Cra1/SOD1
G93A
) mice showed a significantly improved lifespan over SOD1 
littermates, as well as delayed disease progression.  However, neuropathalogical 
examination of cervical and lumbar spinal cords at end stage showed both 
Cra1/SOD1
G93A 
and SOD1
G93A 
exhibited striking degeneration of motor neurons.  This 
indicates that further experiments are needed to check motor neuron loss in each 
genotype group at specific timepoints prior to end stage to identify differences in the 
degree of motor neuron loss (Teuchert, Fischer et al. 2006). 
 
The data demonstrates that mutations in dynein lead to a decrease in motor neuron 
death in SOD1
G93A
 mice, but that the rescue of the SOD1 phenotype in Cra1/SOD1
G93A
 
mice by the Cra1 mutation is less dramatic than with Loa/SOD1
G93A
 mice.  This 
difference could be due to the difference in locations of the mutations on dynein heavy 
chain, or due to genetic backgrounds as different strains carry the Loa and Cra1 
mutations (Teuchert, Fischer et al. 2006). 
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Establishing that two different DHC mutations, both of which cause axonal trafficking 
defects, can rescue the phenotype of a SOD1 model of ALS, suggests the importance of 
axonal transport in understanding the degeneration of motor neurons. 
 
Both Loa and Cra1 predominantly affect motor neurons and were demonstrated to 
rescue the SOD1 phenotype, however, the Swl mutation predominantly affects sensory 
neurons.  Chen et al. (Chen, Levedakou et al. 2007), used Swl to see if a dynein 
mutation that is also located in DHC, but affects sensory rather than motor neurons, is 
also able to rescue the SOD1
G93A
 phenotype.  They crossed Swl with SOD1
G93A
 and 
assessed disease progression and lifespan of the resulting Swl/SOD1
G93A
 double 
heterozygote progeny. 
 
Unlike Loa and Cra1, Swl/SOD1
G93A
 mice showed no difference in average survival 
time compared to SOD1 mice.  Similarly, there was no difference in body weight 
between Swl/SOD1
G93A 
and SOD1, indicating no delay in disease progression (Chen, 
Levedakou et al. 2007).  Together, this data indicates that the Swl mutation does not 
rescue the SOD1 phenotype and suggests that a mutation in dynein may only be capable 
of rescuing the SOD1 phenotype if it causes a defect in motor neurons; a mutation 
causing a sensory neuronal defect is not sufficient. 
 
Interestingly, mutations in dynein are not unique in being able to rescue the SOD1 
phenotype.  Human mutations in the essential enzyme, glycyl-tRNA synthetase 
(GARS), cause motor and sensory axon loss in the peripheral neuron system, leading to 
a range of phenotypes such as Charcot-Marie-Tooth neuropathy to a severe infantile 
form of spinal muscular atrophy (SMA) (Banks, Bros-Facer et al. 2009). 
 
A mouse model of this contains a point mutation resulting in a change of cysteine to 
arginine at residue 201, Gars
C201R
.  Heterozygous Gars
C201R
 mice show reduced grip 
strength, disrupted fine motor control and reduced axon diameter in peripheral nerves.  
Interestingly, when crossed with SOD1
G93A
 mice the double heterozygotes 
(SOD1
G93A
/Gars
C201R
) show a similar rescue of the SOD1 phenotype as seen in Loa, 
with a significantly increased lifespan of approximately 29%.  The SOD1
G93A
/Gars
C201R 
also demonstrates a significant delay in disease progression (Banks, Bros-Facer et al. 
2009). 
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GARS is vital for translation to occur in all cells, and in neurons is active in the 
periphery as well as the cell body.  It is therefore essential for numerous functions of 
neuronal development and maintenance, such as axon guidance, cell migration and cell 
polarity (Banks, Bros-Facer et al. 2009).  It could therefore be one of these many 
functions that is defective in Gars
C201R 
that results in the rescue of the SOD1 phenotype. 
 
This data suggests that a function that is defective in Loa, Cra1 and Gars
C201R
, but not 
in Swl is likely to play a major role in ameliorating the effect of the SOD1 mutation. 
 
I.5.5  Abnormal rear leg (Arl) 
 
A separate ENU mutagenesis programme conducted at the Centre for Modelling 
Human Disease (CMHD) in Toronto, Canada, resulted in another mouse that exhibited 
a similar phenotype to Loa and Cra1.  Male C57BL/6 male mice were treated with 
ENU and mated with C3H/HeJ females.  A resulting female was identified with 
twisting and clenching of the hindlimbs when suspended by the tail, and due to the 
appearance of the phenotype the mutation was named Abnormal rear leg (Arl).  This 
mouse was crossed with a WT C3H/HeJ male and the resulting offspring were also 
affected, confirming this was an autosomal dominant trait.   
 
To map this mutation 85 polymorphic markers were used by the CMHD to genotype 11 
affected and 10 unaffected mice.  The mutation was mapped to the distal region of 
Mmu12 between D12Mit167 (47cM; 100.6Mb) and the telomere (116Mb). 
 
Due to the similarity of this mutation to Loa and Cra1 it was sent to the Fisher group at 
UCL for further positional cloning, where much work on Loa had previously been 
conducted.  As both Loa and Cra1 arise from mutations in Dync1h1 in the 55cM region 
of Mmu12 (Hafezparast, Klocke et al. 2003) – the same region as this new mutation – it 
seemed that Dync1h1 was a likely candidate gene for this mutation.  This gene was 
sequenced in mutant and WT littermates and a 3616T→C transition mutation was 
identified, causing a change of tryptophan to arginine at residue 1206 (Bros-Facer, 
Golding et al. Manuscript in preparation). 
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Arl appears to be more severe than either Loa or Cra1 as no homozygous mutants 
(Arl/Arl) have been born.  Tests have not identified any Arl/Arl embryos after E10.5, 
whereas in both Loa and Cra1 homozygous mutant are born, but die within 24 and 48 
hours respectively. 
 
As the twisting and clenching phenotype is typical of a neuromuscular defect and 
occurs in the hindlimbs, the muscle force of two hindlimb muscles were examined; the 
EDL and TA muscles.  At 90 and 100 days no differences were seen in Arl/+ compared 
to WT, but 1 year old Arl/+ mice exhibited significant reduction in muscle force of TA 
muscles compared to WT.  No significant difference in EDL muscles was identified 
(Bros-Facer, Golding et al. Manuscript in preparation). 
 
The fact that a decrease in maximum force is not detected in TA muscles in Arl/+ mice 
until they are aged 1 year may suggest that a subtle disease phenotype is starting to 
exhibit in the Arl/+ mice.  Therefore more aged mice need to be used to repeat these 
experiments. 
 
EDL muscles in 1 year old mice were also checked for functional motor units, which 
showed no difference in number comparing Arl/+ and WT.  The muscle contraction 
profiles of these EDL muscles were also investigated.  EDL muscles are mainly 
composed of fast fibres which rapidly fatigue when stimulated repeatedly.  In Arl/+ 
mice these muscles showed a similar phenotype to WT, with rapid fatigue after repeated 
stimulation, resulting in Fatigue Index (FI) values that are not significantly different for 
each genotype (Bros-Facer, Golding et al. Manuscript in preparation). 
 
Due to the reduction in TA muscle force in Arl/+ mice, the oxidative capacity of TA 
muscle fibres was tested by staining with the oxidative enzyme, succinate 
dehydrogenase (SDH).  This showed that in Arl/+ the TA muscles had a normal pattern 
of staining, indicating a low oxidative capacity, similar to the TA muscles in WT (Bros-
Facer, Golding et al. Manuscript in preparation). 
 
A significantly greater number of motor units innervate the TA muscles making 
measurements of motor unit number unreliable.  Although this meant a comparison 
could not be made between Arl/+ and WT, a difference seemed unlikely as motor 
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neuron survival assays have shown no significant motor neuron loss in Arl/+ mice 
compared to WT littermates. 
 
Motor neuron survival in 1 year old Arl/+ mice was compared against WT mice in 
lumbar spinal cord sections.  Nissl staining showed no significant difference in the 
number of motor neurons, however, a significant difference was identified in the area of 
the motor neuron soma which were ~ 20% smaller in Arl/+ neurons compared to WT.  
Overall, a greater number of smaller motor neurons were identified in Arl/+ compared 
to WT (Bros-Facer, Golding et al. Manuscript in preparation). 
 
Consequently, the cross-sectioned area of sciatic nerves from 1 year old Arl/+ and WT 
littermates were analysed and compared.  Cross sections immunolabelled for NFs 
showed a 50% reduction in sciatic nerve area in Arl/+ compared to WT (Bros-Facer, 
Golding et al. Manuscript in preparation).  However, because mice younger than 1 year 
did not show any deficit in muscle physiology, they were not further tested.  Therefore, 
it is currently not established whether this smaller cross sectional area in sciatic nerve 
develops over 1 year, or if it presents at developmental stages.   
 
The decrease in sciatic nerve area is likely to be due to the increase in motor neurons 
with smaller soma areas, however, the reason for the decrease in motor neuron soma 
area is unclear.  Further studies are required to establish the cause of the reduction in 
motor neuron soma and sciatic nerve areas seen in Arl/+ mice.  Also, more aged mice 
should be used to repeat these experiments to identify if any motor neuron loss is 
exhibited at later stages and whether the sciatic nerve area shows any change in size in 
Arl/+ compared to WT at later stages. 
 
Peripheral nerve excitability was measured in 14 week and 1 year old Arl/+ and WT 
mice, using the caudal nerve of the tail.  Arl/+ mice exhibited abnormal excitability 
properties compared to WT mice, particularly at 1 year.  The difference between the 
Arl/+ and WT became more significant with age, as WT excitability recordings change 
over time, but the Arl/+ recordings remained mainly the same.  This apparent lack of 
normal development could be related to the smaller cell bodies of motor neurons and 
reduced cross-sectional area of the sciatic nerves in Arl/+ compared to WT, but the 
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exact nature of the phenotype is currently unclear (Bros-Facer, Golding et al. 
Manuscript in preparation). 
 
As with the other dynein mutations, Loa and Swl, the retrograde axonal transport was 
investigated using the fluorescent fragment of tetanus toxin (TeNT Hc).  Using motor 
neurons cultured from E13 Arl/+ and WT embryos, the analysis showed similar speeds 
in both genotypes (Bros-Facer, Golding et al. Manuscript in preparation). 
 
I.5.6  Arl and SOD1 
 
To determine whether Arl was similar to Loa and Cra1 in attenuating disease in 
SOD1
G93A
 mice, or whether it was similar to Swl in being unable to delay disease, the 
Arl was crossed with SOD1
G93A
. 
 
Assessment of muscle force and motor neuron units was used to determine whether 
Arl/SOD1
G93A
 double heterozygotes were able to rescue the SOD1 phenotype.  The 
muscle force was compared between Arl/SOD1
G93A
 and SOD1 in both TA and EDL 
muscle. Despite a trend in improvement of muscle performance of Arl/SOD1
G93A
 mice 
compared to SOD1, it is not significant.  Similarly, the number of motor units and the 
fatigue profiles of Arl/SOD1
G93A
 mice show a similar trend in improved performance 
compared to SOD1, but it is not significant (Bros-Facer, Golding et al. Manuscript in 
preparation).   
 
This data suggests that Arl is similar to Swl in being unable to rescue SOD1 disease 
progression. 
 
I.5.7  Axonemal dynein mutation 
 
Recently, it has been reported that the Arl mice contain a mutation in axonemal dynein, 
in addition to that in cytoplasmic dynein (Golding, unpublished data).  The mutation is 
a point mutation in Dnah11 (also known as left-right dynein, lrd) which is involved in 
establishing the left-right axis in developing embryos and is expressed in the embryonic 
node, essential for development of left-right asymmetry (Supp, Brueckner et al. 1999). 
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The situs inversus viscerum (iv) mouse is due to a mutation in Dnah11.  Adult iv/iv 
mice show an incidence of approximately 50% of inverted visceral organ positioning, 
suggesting that Dnah11 is involved in normal organ positioning.  Without it, the process 
occurs randomly (Layton 1976). 
 
This mouse model is similar to the human autosomal recessive condition, situs inverus, 
which causes the position of the visceral organs to be reversed in the body.  25% of 
situs inversus individuals also have a condition called primary ciliary dyskinesia (PCD), 
a dysfunction of the cilia during embryonic development.  Normally, cilia are involved 
in determining the position of internal organs during development, so dysfunction of the 
cilia can lead to situs inversus (~50% of PCD patients also have situs inversus).  
Individuals suffering from both conditions are said to have Kartagener syndrome, which 
results in recurrent upper respiratory tract infections, and in males, infertility due to 
non-functioning cilia in spermatozoa (Afzelius 1976; Splitt, Burn et al. 1996). 
 
The presence of an axonemal mutation in Arl mice was initially identified as abnormal 
cilia were noticed in the embryonic node of Arl embryos.  Consequently, Arl/iv double 
heterozygotes were produced to check axonemal dynein function and were found to 
suffer from randomised situs inversus.  Thus suggesting that Arl mice have impairment 
of axonemal dynein function that may result in a phenotype similar to that of iv mice.  
A point mutation of A6239T in Dnah11 was identified, resulting in a change of 
aspartate to valine (Golding, unpublished data). 
 
 
 
 
 
 
 
 
 
 
 
 
  
40 
I.6  Aims of the project 
 
Previous investigations have shown that mutations in the heavy chain of cytoplasmic 
dynein can lead to a range of similar phenotypes in the mouse (Hafezparast, Klocke et 
al. 2003; Chen, Levedakou et al. 2007; Dupuis, Fergani et al. 2009).  Arl is a novel 
mutation in the heavy chain of cytoplasmic dynein, but unlike the other dynein 
mutations, Arl is located close to the motor domain so motor function of the protein 
may be impaired. 
 
To investigate what effect the mutation has on the function of dynein, cell extracts from 
homogenised tissue have been used to determine whether protein levels are affected.  
Sucrose density gradient centrifugation has been used to establish if the integrity of the 
dynein complex is disrupted.  Dynein protein has been isolated through a process of MT 
binding and release, then further purified on a continuous sucrose density gradient.  
This purified protein has been analysed to verify its purity and confirm that all subunits 
were present. 
 
The purified dynein samples have been used in MT gliding assays to look for 
differences in MT movement between WT and Arl/+.  In addition to this ATPase assays 
looked for an effect on the hydrolysis of ATP.  Finally, MT binding assays investigated 
whether the mutation affects the binding of MTs by the dynein complex. 
 
In addition to this, mouse embryonic fibroblasts (MEFs) isolated from WT and Arl/+ 
embryos have been used as an in vitro model system to investigate the effects of the Arl 
mutation on cargo transport.  A range of dynein cargos have been tested, including the 
reassembly of Golgi after disruption, and the transport of endosomes using the 
internalisation of fluorescently tagged epidermal growth factor (EGF).  Furthermore, 
the transport of mitochondria have been analysed to establish whether the mutation 
affected their cellular transport. 
 
Moreover, transmission electron microscopy was used to ascertain the effects of Arl on 
neuronal cells from lumbar spinal cord of adult mice.  Golgi and mitochondria 
morphology was investigated.  Consequently, the function of mitochondria isolated 
from lumbar spinal cord tissue was also tested. 
  
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER II 
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Chapter II 
 
 
MATERIALS AND METHODS 
 
 
All chemicals are from Sigma-Aldrich, unless otherwise stated.  All cell biology media 
are from Invitrogen, unless otherwise stated. 
 
II.1  Buffers and media 
 
 Lysis buffer  0.1 M Tris 
0.2% (w/v) SDS 
0.2 M NaCl 
0.5 mM EDTA 
 
 2D lysis buffer  7 M Urea 
2 M Thiourea 
4% (v/v) CHAPS 
65 mM DTT 
 
 Sample buffer  0.125 M Tris-Cl 
4% (w/v) SDS 
20% (v/v) Glycerol 
0.2 M DTT 
0.02% Bromophenol blue 
 
 PBS-   Phosphate buffered saline without Mg2+ or Ca2+ 
 
 Homogenisation buffer pH 6.8 
80 mM KPIPES 
1 mM EGTA 
2 mM MgSO4 
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 BRB80 buffer  pH 6.8 
80 mM KPIPES 
2 mM MgCl2 
0.5 mM EGTA 
 
 Motility buffer  pH 6.7 
20 mM KPIPES 
10 mM K-acetate 
4 mM MgSO4 
 
 ATPase assay buffer pH 7.5 
2 mM MgCl2 
1 mM DTT 
1 mM ATP 
3 mM Phosphoenol pyruvate 
0.2 mM NADH 
50 mM Tris-acetate 
1.75% (v/v) Pyruvate kinase/lactate dehydrogenase 
 
 Complete DMEM  DMEM (Dulbecco’s modified eagles medium) 
1% (v/v) Penicillin/streptomycin 
1% (v/v) L-glutamine 
15% (v/v) Foetal calf serum (Hyclone) 
 
 CO2 Independent  CO2 independent medium 
medium   1% (v/v) Penicillin/streptomycin 
1% (v/v) L-glutamine 
 
 Complete L-15  L-15 medium 
medium   5% (w/v) Glucose 
1% (v/v) Penicillin/streptomycin 
20 nM Progesterone 
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2% (v/v) Horse serum 
5 µg/ml Insulin 
10 mM Putrescine 
10 µg/ml Coalbumin 
30 nM Sodium selenite 
 
 Motor neuron medium Neurobasal medium 
2% (v/v) B27 supplement 
25 µM β-mercaptoethanol 
2% Horse serum 
25 µM Glutamine 
0.1% (v/v) Fungizone 
1% (v/v) Penicillin/streptomycin 
 
 Tissue homogenisation pH 7.5 
buffer   0.3 M Manitol 
    20 mM MOPS 
    2 mM EDTA 
 
 O2 Electrode buffer pH 7.4 
0.2 M Manitol 
1 mM K-Phosphate 
50 mM KCl 
1 mM MgCl2 
10 mM MOPS 
 
 
 
 
 
 
 
 
 
  
Primary Antibody Company Order code Concentration used 
anti-Dynein heavy chain, rabbit polyclonal IgG Santa Cruz Biotech SC-9115 1/200 – Western blot 
anti-Dynein intermediate chain, 74.1kDa mouse 
monoclonal 
Dr Kevin Pfister / 1/1000 – Western blot 
anti-P150
Glued
, mouse polyclonal IgG BD Transduction Labs 610473 1/500 – Western blot 
anti-α-tubulin, DM1A mouse monoclonal IgG Upstate 05-829 0.5µg/ml – Western blot 
anti-Giantin, rabbit polyclonal Covance PRB-114C 1/1000 - Immunofluorescence 
    
Secondary Antibody    
Goat anti-rabbit IgG, Alkaline phosphatase (AP) 
linked 
Sigma A3812 1/10,000 – Western blot 
Goat anti-mouse IgG, AP linked Sigma A3562 1/10,000 – Western blot 
Rabbit anti-mouse polyclonal IgG, HRP linked Dako Cytomation P0260 1/30,000 – Western blot 
Donkey anti-rabbit IgG, HRP linked GE Healthcare NA934 1/30,000 – Western blot 
    
Fluorescent Antibody    
EGF-Alexa Fluor 555 streptavidin complex Invitrogen E35350 10ng/ml – Immunofluorescence 
Alexa Fluor 488 conjugate goat anti-mouse IgG Molecular Probes A11029 1/200 – Immunofluorescence 
Alexa Fluor 546 conjugate goat anti-rabbit IgG Molecular Probes A11035 1/200 - Immunofluorescence 
 
Table 2.  Antibodies  
Table giving details of antibodies used during experiments and optimised concentrations.  AP = alkaline phosphatase linked secondary antibody, HRP = horseradish 
peroxidise linked secondary antibody.  AP-linked antibodies were used with the CDP-STAR chemiluminescence system (Sigma) to detect proteins, HRP-linked antibodies 
were used with the Supersignal West Dura substrate (Pierce) to detect proteins.  
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II.2.1  Genotyping 
 
For genotyping, adult tail biopsies were digested using tail lysis buffer and proteinase K 
overnight at 55
o
C.  Samples were centrifuged to pellet undigested tissue.  The 
supernatant containing genomic DNA was collected and diluted 50X in PCR grade 
water. 
 
PCR used 1X Hotstart Taq Mastermix (Qiagen) and 0.5 µM each of forward and reverse 
primer (Arl-F: 5’-CAC TCC AGA TGC ACA GTG CTC TCC AAC CAC -3’; Arl-R: 
5’- CCC ACT CAC CCT CGA TGT TGT CAA TGT AAA CCC -3’).  
 
After the initial denaturation of 95
o
C for 15 min, thirty five cycles of PCR were 
performed.  Denaturation was at 94
o
C for 30 sec, primer specific annealing temperature 
of 63
o
C for 30 sec was used, and then extension of 72
o
C for 1 min.  A final extension of 
72
o
C for 10 min was then performed.  5 µl of PCR product was analysed on 1% agarose 
gel to check for amplification. 
 
PCR products were digested for 1.5 hr at 37
o
C with AvaI (New England Biolabs) 
restriction enzyme and run on a 3% agarose gel.  An AvaI restriction site is present in 
the mutant sequence only, allowing the mutant PCR product to be distinguished from 
wildtype PCR product after digestion.  The wildtype genotype produces one band of 
270 bp, heterozygotes produce three bands of 270 bp, 235 bp and 35 bp, while 
homozygous mutants produce two bands of 235 bp and 35 bp. 
 
PCR to genotype for the axonemal dynein mutation used 1X Hotstart Taq Mastermix 
(Qiagen) and 0.5µM each of two forward (WT and mutant) and one common reverse 
primer (Axo-F Mut: 5’-TCA TGA GAG CAT TGA GGG A-3’; Axo-F WT: 5’-TCA 
TGA GAG CAT TGA GGG T-3’ and Axo-R: 5’-TGA CTA TCG TAC AAA ATG 
CTT-3’) 
 
After the initial denaturation of 95
o
C for 15 min, thirty five cycles of PCR were 
performed.  Denaturation was at 94
o
C for 30 sec, primer specific annealing temperature 
of 55
o
C for 30 sec was used, and then extension of 72
o
C for 1 min.  A final extension of 
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72
o
C for 10 min was then performed.  5 µl of PCR product was analysed on 1% agarose 
gel to establish genotype. 
 
II.2.2  SDS-PAGE and Western Blotting 
 
For SDS-PAGE analysis, protein samples were denatured by boiling for 5 minutes in 
5X SDS sample buffer (final concentration 1% SDS).  The protein samples were then 
separated by SDS-PAGE using either the Mini Protean gel electrophoresis system from 
Biorad using 4% and 10%  gels (as indicated for each experiment), or the XCell 
Surelock MiniCell system from Invitrogen with 4-12% gradient gels.  Electrophoresis 
was conducted at a constant voltage of 120V for approximately 1.5 hr (or until the dye 
front reached the bottom of the gel).  Protein bands were either visualised by coomassie 
blue staining, following the manufacturers instructions (Sigma), or transferred to 
polyvinylidene difluoride (PVDF) membrane from GE Healthcare for Western blotting.  
Membranes were immersed in methanol for 30 sec, then rinsed in water, prior to 
transfer to improve the transfer of proteins into the membrane.  The polyacrylamide gels 
and membranes were “sandwiched” together between filter paper and sponge pads that 
had been soaked in transfer buffer and then secured in the transfer cassette (sponge pad-
filter paper-gel-membrane-filter paper-sponge pad).  Frozen cooling units were placed 
into the transfer tanks with the cassettes to prevent significant temperature increase from 
the current and transfers were also conducted at 4
o
C for this reason.  The transfers were 
conducted at 20V overnight (with an additional 30 min at 90V when transferring very 
large proteins such as DHC).  Blots were disassembled, rinsed in PBS containing 0.5% 
Tween-20 (PBST) and incubated in 5% w/v non-fat milk at room temperature for 1 hr 
on a rocking plate.  The membranes were then rinsed in PBST and labelled with the 
primary antibody (as indicated) at room temperature for 1 hr on a rocking plate.  The 
membranes were washed with PBST 1 x 15 min and 3 x 5 min on a rocking plate and 
then labelled with secondary antibody at room temperature for 45 min on a rocking 
plate.  The secondary antibody was removed and the membranes washed in PBST 3 x 
15 min on a rocking plate.  The proteins were detected using alkaline phosphatase-
linked secondary antibodies with the CDP-STAR chemiluminescence system (Sigma), 
or the Horseradish Peroxidase-linked secondary antibodies with the Supersignal West 
Dura substrate (Pierce) (See Table 2 for antibody details).  Multiple film exposures were 
taken from the membranes over a range of exposure times (between 10 sec and 10 min 
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depending on protein), and those below saturation were used for quantification.  To 
quantify, the film images were scanned using an image scanner with ImageMaster 
Labscan V3.01 software (Amersham Biosciences).  The signal from the bands was 
determined, and the background intensity from the film was subtracted using the 
ImageQuant TL 2005 software (Amersham Biosciences).  GraphPad Prism software 
was used for statistical analysis using Mann-Whitney t test.  Significance was set as 
p<0.05. 
 
II.2.3  Dynein Quantification in Brain Tissue 
 
Adult wildtype and Arl/+ mice were sacrificed by terminal CO2 anaesthetisation and the 
brains collected.   The tissue was weighed, then homogenised using a tight glass hand 
held Teflon homogeniser.  This was done in a 1:4 ratio of tissue to 2D lysis buffer at 
room temperature to prevent the urea from crystallising if performed on ice. After 
homogenisation, the homogenate was left at room temperature for 30 min to allow 
solubilisation of the proteins; it was then centrifuged at 13,000 rpm for 20 min. The 
supernatant was then collected and the protein concentration measured using the 2D 
Quant kit (GE Healthcare) following the manufacturer’s protocol.  The standard BCA 
kit (Pierce) could not be used to measure the protein concentration as the urea, CHAPS 
and DTT would interfere with the kit. The 2D Quant kit precipitates the protein, 
allowing for the removal of interfering substances in solution.  5 μg of each sample was 
boiled at 95
o
C for 10 min in 5 X sample buffer (SB), then loaded onto a 4% and 10% 
SDS-PAGE gel and Western blotting conducted as previously described, with detection 
for DHC and α-tubulin and alkaline phosphatase (AP)-linked secondary antibodies 
(1/10,000) (See table 2). 
 
II.2.4  Dynein Quantification in Spinal Cord 
 
Adult wildtype and Arl/+ mice were sacrificed by terminal CO2 anaesthetisation and the 
spinal cords collected.  The tissue was weighed, then homogenised using a tight glass 
hand held Teflon homogeniser.  This was done in a 1:3 ratio of tissue to 2D lysis buffer.  
After homogenisation, the homogenate was left at room temperature for 30 min to allow 
solubilisation of the proteins; it was then centrifuged at 13,000 rpm for 20 min.  The 
supernatant was then collected and the protein concentration measured using the 2D 
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Quant kit following the manufacturer’s protocol.  5 μg of each sample was boiled at 
95
o
C for 10 min in 5 X SB, then loaded onto a 4% and 10% SDS-PAGE gel and 
Western blotting conducted as previously described, and labelled with DHC and α-
tubulin and alkaline phosphatase (AP)-linked secondary antibodies (1/10,000) (See 
table 2). 
 
II.2.5  Sucrose Density Gradient Analysis 
 
Adult wildtype and Arl/+ mice were sacrificed by terminal CO2 anaesthetisation and the 
brains collected.   The tissue was weighed, then homogenised on ice using a tight glass 
Teflon hand homogeniser, in PBS
-
, containing 1X protease inhibitors (Roche) in 1:4 
tissue to buffer ratio.  The homogenate was centrifuged at 13,000 rpm for 20 min at 4
o
C, 
the pellets discarded and the supernatant retained.  The protein concentrations were 
established using the Pierce BCA Protein Assay kit, following the manufacturer’s 
protocol.  2 mg of protein from each sample was loaded onto 5-25% linearised sucrose 
density gradients and centrifuged at 50,000 rpm (~303,800 x gmax) at 4
o
C for 4 hr.  Nine 
equal fractions were gently pipetted from the top of the gradient using wide bore pipette 
tips to minimise disturbance to the gradient.  These fractions were snap frozen in liquid 
nitrogen (LN2), then 16 μl of each sample boiled at 95
o
C for 10 min in 5 X SB and then 
analysed on 4% and 10% SDS-PAGE gels and Western blotting (as previously 
described) then labelled for DHC (1/200) (Santa Cruz) and DIC (1/2000) (Gift from Dr 
Kevin Pfister) and alkaline phosphatase (AP)-linked secondary antibodies (1/10,000) 
(See table 2). 
 
II.2.6  Dynein Purification 
 
Thirty adult wildtype and Arl/+ mice were sacrificed by terminal CO2 anaesthetisation 
and the brains dissected.  The tissue was kept on ice in ice-cold PBS
-
, then drained and 
weighed.  Any blood was rinsed away with PBS
-
 and the tissue homogenised in 
homogenisation buffer with ATP (HB/ATP) using a polytron at 4
o
C.  The wildtype and 
Arl/+ homogenates were centrifuged in a Sorvall SS34 rotor at 11 krpm (~15,000 x gav) 
at 4
o
C for 1 hr.  The pellets were discarded and the supernatants centrifuged at high 
speed to remove as much membrane material as possible, using a Beckman SW55Ti 
rotor at 32.5 krpm (~100,000 x gav) at 4
o
C for 1 hr.  The supernatants were collected and 
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the pellets discarded.  To remove most of the microtubule associated proteins (MAPS) 
from the supernatants, the endogenous tubulin was polymerised using GTP to aid 
polymerisation and taxol to polymerise irreversibly (0.25 mM GTP and 6 μM taxol) and 
incubated at 30-35
o
C for 30 min.  The supernatants were then centrifuged at 20 krpm 
(~37,000 x gav) at 28
o
C for 30 min, again in a Beckman SW55Ti rotor.  The resulting 
pellets were discarded and to the supernatants apyrase, AMP.PNP and taxol were added 
(1 U/ml apyrase, 50 μM AMP.PNP and 4 μM taxol).  This was to bind the dynein to the 
microtubules using the non-hydrolysable analogue of ATP; AMP.PNP.  This was 
incubated at 35
o
C for 30 min.  Approximately 2 ml of 20% sucrose in HB and taxol 
were used as a cushion in two 5 ml centrifuge tubes.  The supernatants were layered 
over the cushions and centrifuged at 32.5 krpm (~100,000 x gav) for 45 min at 25
o
C in an 
SW55Ti rotor.  The supernatants and cushions were aspirated (a sample was kept to 
check if dynein remained in this sample) and the remaining pellets resuspended in 1/10
th
 
the original volume of the high speed supernatant of HB using a small, hand-held, glass 
homogeniser.  The resuspended pellets were layered over 10% sucrose cushions and 
centrifuged at 17.8 krpm (~30,000 x gav) for 30 min at 28
o
C.  Again the supernatants and 
cushions were removed and samples kept to check if dynein remained.  The pellets were 
resuspended using a small glass, hand-held homogeniser in 1/20
th
 the original 
supernatant volume of HB/KCl/taxol/ATP.  This was incubated for 30 minutes at 37
o
C 
to elute the kinesin and dynein.  This time, without a cushion, the resuspended samples 
were centrifuged at 17.8 krpm (~30,000 x gav) for 30 min at 28
o
C and the resulting 
supernatants were collected and stored on ice at 4
o
C.  These were labelled motor sample 
1.  The pellets were resuspended in 1/50
th
 the original volume of HB/KCl/ATP and left 
on ice at 4
o
C overnight.  5-20% sucrose density gradients were poured and allowed to 
linearise overnight.  The following morning, the resuspended pellets were centrifuged at 
17.8 krpm (~30,000 x gav) for 30 min at 4
o
C, the supernatants collected and labelled as 
motor sample 2.  All of the motor samples 1 and 2 were loaded onto individual sucrose 
gradients and centrifuged at 52krpm (~255,800 x gav) for 4 hr and 35 min at 4
o
C with the 
brake set to low.  Once complete, 12 equal fractions were collected from each of the 
gradients and left on ice at 4
o
C before being assayed for motility under the microscope 
the following day.  Samples from each of the fractions were run on a 4-12% gradient 
SDS-PAGE and Western blotted (as previously described) and labelled for dynein heavy 
chain and intermediate chain and alkaline phosphatase (AP)-linked secondary antibodies 
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(1/10,000), to check for the presence and location of the dynein in the samples (See table 
2). 
 
II.2.7  Tubulin Polymerisation 
 
MTs were polymerised using 10 µl aliquots of 5 mg/ml stock tubulin in BRB80 buffer.  
To this was added, 1 mM GTP, 1X protease inhibitors (Roche), then warmed to RT and 
20 µM paclitaxel added to a final volume of 20 µl in BRB80 buffer.  This was then 
incubated at 35
o
C for 30 min.  The sample becomes viscous and bubbles may appear if 
MTs have successfully been formed. 
 
II.2.8  MT Gliding Assay 
 
The MT gliding assays were performed using protocols kindly provided by Professor 
Viki Allan (University of Manchester) and Professor Rob Cross (Warwick University).  
Flow chambers were constructed from microscope slides, with two strips of high 
vacuum grease run along either side, and a coverslip placed on top.  This produced a 
chamber of approximately 15-20 µl volume.  To the chamber, 2.5 mg/ml casein was 
added to coat the glass coverslip, preventing denaturing of the dynein once added.  The 
casein was incubated at room temperature for 2 min.  This was then washed out using 
motility buffer.  Approximately 15 µl of the purified dynein fraction was flowed into the 
chamber and incubated in a humid chamber at room temperature for 2-5 min.  The 
chamber was rinsed with 2 X volumes of motility buffer containing 150 µg/ml casein 
and 1 mM DTT.  The microtubule dilution was then flowed through the chamber, 
allowed to bind to the dynein for a minute and then viewed using an Olympus VE-DIC 
equipped, upright microscope with a 60X Plan Apo 1.4 numerical aperture DIC 
objective, through a Hamamatsu Argus image processor.  Once MTs were identified and 
focussed upon, any moving ones were recorded for 1 min periods at 1 frame per second.  
After filming was completed, the videos were analysed to measure the velocities of the 
moving MTs using the Retrac program developed by Nick Carter in the laboratory of 
Rob Cross (previously of the Marie Curie Research Institute, now the Centre for 
Mechanochemical Cell Biology, Warwick University).  Table 3 details optimisations 
that were made to this protocol to improve the levels of MT motility observed.  These 
conditions were developed in conjunction with Dr Kuniyoshi Kaseda (previously of the 
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Marie Curie Research Institute, now at the Saravio Institute, Japan), based on his 
anecdotal evidence from using this protocol. 
 
II.2.9  Microtubule-dependent ATPase Assay 
 
Tubulin was polymerised to MTs and stabilised with paclitaxel.  The MTs were added to 
the purified dynein fraction in 1ml of ATPase assay buffer.  This mixture was added to a 
quartz cuvette and placed in a spectrophotometer set at 37
o
C.  The change in absorbance 
at 340 nm was measured and recorded over a 5 min timeframe. 
 
II.2.10  MT Binding Assay 
 
To 20 µl of polymerised MT sample, 20 µg of purified dynein sample was added and 
gently mixed.  To this, 50 µM AMP.PNP was added to bind the dynein to the MTs, and 
incubated at 30
o
C for 15 min.  500 µl of 10% sucrose was placed into a 2 ml centrifuge 
tube and the MT/dynein sample layered over the top.  This was centrifuged at 30 krpm 
(106,500 x gav) for 40 min at 25
o
C.  The top sample was removed (the combined volume 
of MTs and dynein sample) and labelled supernatant and the 500 µl of sucrose cushion 
removed and labelled cushion.  The pellet was washed in 100 µl of BRB80 buffer and 
centrifuged again at 30 krpm (106,500 x gav) for 40 min at 25
o
C.  The wash buffer was 
removed and discarded and the pellet solubilised in 20 µl of BRB80 buffer.  Each 
sample was run on an SDS-PAGE and analysed by western blot (as previously 
described) for DHC, DIC and α-tubulin (1/1000) (Upstate) and alkaline phosphatase 
(AP)-linked secondary antibodies (1/10,000) (See table 2) and quantified using Image 
Pro software. 
 
II.3.1  Collection and Culture of Mouse Embryonic Fibroblasts 
 
Pregnant female Arl/+ mice were sacrificed by terminal CO2 anaesthetisation and the 
uterine horns dissected out and placed in phosphate buffered saline, without bivalent 
cations (PBS
-
).  Each embryo was separated from its placenta and the brain and red 
organs removed, then finely minced in PBS
-
 using a razor blade.  The tissue from each 
embryo was then digested in 2 ml of trypsin-EDTA (0.05% trypsin and 0.53 mM 
EDTA-4 Na) for 15 min, with occasional shaking. DMEM supplemented with 15% 
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serum was added to neutralise the trypsin and the cells recovered by centrifugation for 5 
min at 1500 rpm.  The cells from each embryo were transferred to 175 cm
2
 cell culture 
flasks and grown in complete DMEM medium at 37
o
C in 5% CO2 and 3% O2. 
 
II.3.2  Golgi Reassembly 
 
MEFs were seeded at a density of 2.0x10
5 
cells/well in a 6 well plate, on round 
coverslips, in complete DMEM medium.  The cells were allowed to proliferate at 37
o
C 
in 5% CO2 and 3% O2 until 70% confluency was reached.  The medium was replaced 
with chilled complete DMEM with 15mM HEPES and the cells incubated on ice for 30 
min.  10 μg/ml of nocodazol was added to each well and incubated for 3 hours at 37oC 
in 5% CO2 and 3% O2.  The nocodazol was aspirated and the 0 min timepoint cells 
immediately fixed. All other timepoints were washed five times with plain DMEM as 
quickly as possible. Complete medium was then added and the cells incubated at 37
o
C in 
5% CO2 and 3% O2 to recover for the specified timepoints.  To fix the cells, 2 ml of -
20
o
C methanol was added to each well for 8 min, this was then aspirated and the cells 
were washed twice with phosphate buffered saline containing 0.2% gelatine from cold 
water fish skin (PBSG).  The cells were stained for Golgi using an antibody against 
giantin (1/200) (Covance), a Golgi membrane protein, and α-tubulin.  Alexa-Fluor 
conjugated secondary antibodies were then used (1/10,000) (All from Invitrogen) (See 
table 2).  All antibodies were diluted in PBS
-
 (except anti-giantin which was diluted in 
PBSG), and incubated at room temperature for 30 min.  The coverslips were mounted on 
glass slides using Prolong Gold mounting medium containing DAPI (Invitrogen), and 
left to cure for 24 hr, then stored at 4
o
C.  The slides were imaged using a Deltavision 
Core inverted, widefield microscope system (Applied Precision Inc.) with an Olympus 
60 x Plan Apo 1.4 numerical aperture  (na) oil objective lens.  Imaging was conducted 
using the SoftWorX image processing software (Applied Precision Inc.) with 
appropriate filters (DAPI and TRITC) at 100% neutral density, and exposure times of 
0.2-0.5 sec.  Images were then deconvolved in the SoftWorx imaging program. 
 
II.3.3  Endosomal Trafficking 
 
Wildtype and Arl/+ MEFs were plated at a density of 2.0x10
5
 cells/ well in a 6 well 
plate on round coverslips in complete DMEM.  Cells were allowed to proliferate at 37
o
C 
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in 5% CO2 and 3% O2 until 80% confluency was reached.  The cells were washed twice 
with PBS
-
 and then incubated in starving medium (DMEM containing L-glutamine and 
penicillin and streptomycin, but without serum) for 2 hr at 37
o
C in 5% CO2 and 3% O2, 
before being stimulated for 10 min in starving medium containing 10 ng/ml Alexa 
Fluor-555 conjugated EGF (Invitrogen) and 0.1% BSA.  The cells were washed twice 
with PBS
-
, replaced with fresh serum-free medium and the internalised EGF then chased 
for the indicated timepoints.  Cells were then washed in ice cold PBS
-
 and fixed with 4% 
paraformaldehyde (PFA) (Electron Microscopy Science) for 15 min and permeabilised 
with 0.1% Triton X-100 for 5 min, then washed three times in PBS
-
 and blocked for 30 
min with 2% BSA.  The cells were stained for α-tubulin for 30 min at room temperature 
and mounted using Prolong Gold antifade with DAPI, left to cure for 24 hr and then 
stored at 4
o
C.  The slides were imaged using a Deltavision Core inverted, widefield 
microscope system (Applied Precision Inc.) with an Olympus 60 x Plan Apo 1.4 
numerical aperture  (na) oil objective lens.  Imaging was conducted using the SoftWorX 
image processing software (Applied Precision Inc.) with appropriate filters (FITC, DAPI 
and TRITC) at 100% neutral density, and exposure times of 0.2-0.5 sec.  Images were 
deconvolved in the SoftWorX image processing software. 
 
II.3.4  Endosomal Trafficking in Live Cells 
 
Wildtype and Arl/+ MEFs were plated at a density of 0.5x10
5
 cells/ well in a 2 well, live 
cell imaging chamber in DMEM.  Cells were allowed to proliferate at 37
o
C in 5% CO2 
and 3% O2 until 50% confluency was reached.  The cells were washed twice with PBS
-
 
and then incubated in starving medium (DMEM containing L-glutamine and penicillin 
and streptomycin, but without serum) for 2 hr at 37
o
C in 5% CO2 and 3% O2, before 
being stimulated for 10 min in starving medium containing 20 ng/ml Alexa Fluor-555 
conjugated EGF (Invitrogen) and 0.1% BSA.  The cells were washed once with PBS
-
, 
replaced with fresh serum-free CO2 independent medium and the internalised EGF then 
chased for 1 min movies (at 1 frame per 2 sec), every 5 min for a total of 30 min.  
Images were captured using 2 channels; DIC and TRITC filters on a Personal 
Deltavision (pDV) widefield, live cell imaging microscope system (Applied Precision 
Inc.) using an Olympus 100X Plan Apo 1.4 na oil objective lens.  Neutral density was 
set at 100% for the the DIC channel and 50% for the TRITC channel.  The movies were 
captured using the SoftWorX imaging software (Applied Precision Inc.) and analysed 
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using Image J and Excel to determine the total number of moving endosomes and the 
average velocities of each of the endosome trajectories.  To determine the average 
velocities of the endosomes by calculating the total distance travelled by the endosome, 
as determined by the x and y coordinates provided by Image J, over a set time calculated 
from the number of frames that movement was measured.  This data was used in Excel 
and the following formula used to calculate the distance travelled by the endosome 
being tracked:  
=SQRT(((x2-x1)*(x2-x1))+((y2-y1)*(y2-y1))) 
Where x and y are the location coordinates of the endosome.  The calculated distance 
was then divided by the amount of time the distance was measured over to give the 
speed of movement of the endosome. 
 
II.3.5  Tracking of Mitochondria in Live Cells 
 
Wildtype and Arl/+ MEFs were plated at a density of 0.5x10
5
 cells/ well in a 2 well, live 
cell imaging chamber in DMEM.  Cells were allowed to proliferate overnight at 37
o
C in 
5% CO2 and 3% O2 until 50% confluency was reached.  50 nM of Mitotracker Green 
FM (Invitrogen) was added to the cells in fresh complete medium and incubated for 30 
min at 37
o
C in 5% CO2 and 3% O2.  The medium was replaced with CO2 independent 
medium and cells imaged using DIC and FITC channels on a Personal Deltavision 
(pDV) widefield, live cell imaging microscope system (Applied Precision Inc.) using an 
Olympus 100X Plan Apo 1.4 na oil objective lens.  Neutral density was set at 100% for 
the the DIC channel and 50% for the FITC channel.  The movies of the visualised 
mitochondria were captured using the SoftWorX imaging software (Applied Precision 
Inc.) and were recorded at 1 frame per 2 sec for lengths of 1 min.  The movies were 
analysed using Image J and Excel to determine the average velocities of the 
mitochondria by calculating the total distance travelled by the mitochondria, as 
determined by the x and y coordinates provided by Image J, over a set time calculated 
from the number of frames that movement was measured.  This data was used in Excel 
and the following formula used to calculate the distance travelled by the mitochondrion 
being tracked:  
=SQRT(((x2-x1)*(x2-x1))+((y2-y1)*(y2-y1))) 
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Where x and y are the location coordinates of the mitochondrion.  The calculated 
distance was then divided by the time the distance was measured over to give the speed 
of movement of the mitochondrion. 
 
II.3.6  Culturing of motor neurons 
 
E13 embryos were dissected from the uterine horn and washed in PBS
-
.  They were then 
removed from the embryonic sacs and kept in PBS
-
 on ice.  The brain and red organs 
were removed and the spinal cord dissected from the posterior of the embryo, ensuring 
all connective and membranous tissue was removed.  The meninges and dorsal root 
ganglia were removed and the dorsal root of the spinal cord cut away and discarded.  
The remaining ventral root (containing the motor neurons) was cut into pieces and 
transferred to PBS
-
 containing antibiotics (penicillin and streptomycin).  Spinal cord 
pieces were allowed to settle and then transferred to a 10 ml Falcon tube containing 1 
ml HBSS medium, antibiotics and 10 µl trypsin.  This was incubated for 10 min at 
37
o
C, with gentle shaking.  The spinal cord pieces were transferred to 800 µl of 
complete L15 medium (L15, 100 µl 4% BSA and 100 µl DNaseI).  The cells were 
dissociated through gentle trituration, then allowed to settle for 2 min.  The supernatant 
was transferred to a separate tube and to the pellet was added 900 µl of complete L15 
medium (L15, 100 µl 4% BSA and 20 µl DNaseI) and gently triturated 8 times.  This 
was allowed to settle for 2 min to separate remaining large pieces of tissue and the 
supernatant combined with the first supernatant.  To the remaining pellet 900 µl of 
complete medium was added and gently dissociated again by triturating 8 times.  The 
supernatant was combined with the others and the pellet discarded.  The supernatant 
was centrifuged through a 1 ml BSA cushion for 5 min at room temperature.  The 
supernatant was aspirated and the pellet gently resuspended in 600 µl of Motor neuron 
culture medium and 200 µl seeded per well of 2 well live cell chambers.  A further 800 
µl of Motor neuron culture medium was added to each well and the cells incubated at 
37
o
C in 5% CO2 and 3% O2.  
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II.4.1  Perfusion Fixation Protocol 
 
Adult wildtype and Arl/+ mice were terminally anaesthetised by injection with ketamine 
hydrochloride and medetomidine hydrochloride, then intra-cardiac perfusion-fixation 
was performed using 2.5% gluteraldehyde and 1.5% paraformaldehyde in 100 mM Na 
cacodylate buffer.  The perfusion was carried out in two stages; 50 ml of 100 mM 
cacodylate, followed by 100 ml of fixative.  Perfusion was performed on a down-
draught table to comply with COSHH.  Tissue and muscle was removed from the 
hindlimbs, and the sciatic nerves removed and placed in fixative.  The spinal cord was 
exposed by dorsal laminectomy, sliced at 2-3 mm intervals to facilitate access to tissue 
by the fixative and then placed in fixative.  All tissues were left in fixative for 48 hr to 
harden.  Tissues were immersed in 2% aqueous osmium tetroxide (Electron Microscopy 
Science) for 2 hr at room temperature, then dehydrated sequentially in increasing 
concentrations of ethanol- 70% ethanol, 2 x 10 min; 90% ethanol, 2 x 10 min; 100% 
ethanol, 2 x 10 min.  The tissues were then incubated at room temperature in propylene 
oxide (Agar Scientific) for 2 x 15 min.  Following this, the tissues were infiltrated with 
resin consisting of 1 part polypropylene oxide: 1 part araldite resin (Agar Scientific) for 
one hr on a rotating wheel.  This was discarded and replaced with 1 part polypropylene 
oxide: 2 parts araldite resin for one hr on a rotating wheel, then finally replaced with 
100% pure resin and left overnight to allow tissues to fully infiltrate on a rotating wheel.  
The following morning, sample pot caps were half filled with resin, the tissue from each 
sample placed on top and resin added to cover the tissue.  These were placed in an oven 
at 60
o
C for 48 hr to allow the resin to cure.  Once the resin was cured, the samples were 
sectioned using a microtome to produce multiple 100 nm sections.  Each section was 
placed on a nickel electron microscopy grid, allowed to dry then stained with uranyl 
acetate and lead citrate.  The samples were imaged at 1000 x and 5000 x magnification 
using an Hitachi-7100 transmission electron microscope with an axially mounted Gatan 
Ultrascan 1000 CCD camera. 
 
II.4.2  Preparation of Mitochondria and O2 Consumption Assay 
 
Five adult wildtype and Arl/+ mice were sacrificed by terminal CO2 anaesthetisation 
and the lumbar section of the spinal cords dissected.  The tissue was kept on ice in 
Tissue homogenisation buffer (THB), then homogenised with a loose, glass, handheld 
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homogeniser in approximately 1 ml of buffer, supplemented with 1% BSA and 7 mM L-
cysteine hydrochloride.  The homogenate was centrifuged at 800 x g for 10 min at 4
o
C.  
The supernatants were transferred to a new tube and centrifuged at 10,000 x g for 10 
min at 4
o
C.  The pellets were resuspended in 1 ml of buffer with 1% BSA, but no L-
cysteine hydrochloride and centrifuged again at 10,000 x g for 10 min at 4
o
C.  The 
pellets were then resuspended in 50 µl of Oxygen electrode buffer (OEB) and kept on 
ice.  Using a Rank oxygen electrode, the oxygen consumption of the mitochondria was 
measured.  20 µl of mitochondria, with 5 µl of ascorbate and 5 µl of TMPD were added 
to the electrode chamber in 400 µl of buffer and the rate of O2 consumption measured 
and recorded.  The protein concentration of each sample was then measured using the 
BCA protein quantification kit from Pierce.  The rate of O2 consumption was then 
calculated as nmol O2.min
-1
mg
-1
 and wildtype and Arl/+ mitochondria compared. 
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Chapter III 
 
INVESTIGATING THE EFFECT OF THE ARL MUTATION ON DHC 
PROTEIN 
 
 
III.1 Introduction 
 
As previously explained in chapter I, the Arl mutation results in a change of the well 
conserved tryptophan at position 1206, to arginine in the cytoplasmic dynein heavy 
chain gene 1 (Dync1h1).  This is in a region currently of unknown function, just N-
terminal to the motor domain. 
 
The Arl mutation has been shown to have a related, but more severe phenotype than 
Loa or Cra1, with homozygotes dying by E10, and a more pronounced and earlier onset 
hindlimb clenching in the tail suspension test. 
 
As the mutation is located in an area of unknown function, initial studies looked at the 
effect of the mutation on the protein and its function. 
 
III.2  Effect of mutation on mice 
 
As the Arl mutation is embryonically lethal in homozygous mutants, any experiments 
using adult tissue could only compare WT to heterozygotes.  This means that 
experiments using dynein from heterozygous adult tissue will contain a mixed 
population of WT homodimers, WT-Arl heterodimers and Arl homodimers, likely to be 
in a 1:2:1 ratio.  As some experiments are unable to distinguish which population may 
be causing a particular phenotype it is important that this is taken in to account when 
interpreting data. 
 
Limitations in breeding were encountered, meaning that embryonic tissue was difficult 
to obtain.  Under normal circumstances, mice can be timed mated so that embryos of 
specific ages can be dissected.  However, Arl mice proved to be very poor breeders, 
with very few embryos and normal mendelian ratios of genotypes were not attained.  
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More than 100 timed matings were set up between Arl/+ and Arl/+ mice, resulting in 
only 6 pregnancies.  From these 6 litters, only 2 Arl/Arl embryos were acquired at E10.  
This suggests that lethality due to the mutation may be earlier in development than 
previously thought.   
 
Experiments using timed matings to produce litters of different ages were planned to 
establish at what stage of development the Arl/Arl embryos are lost, as the 
developmental stage at which the homozygous mutants are no longer viable can 
provide information about how the mutation may be affecting the embryo development.  
However, due to the very low levels of breeding in these mice, this was not possible. 
 
Mendelian ratios were not identified in litters from breeding stock.  As Arl is a 
dominant mutation, ratios from F1 backcrosses of Arl/+ x WT should result in 
approximately 1:1 ratios of genotypes.  However, from 901 mice produced from these 
crosses, 265 were Arl/+ and 636 were WT, giving a ratio of 1 : 2.4.  This suggests that 
some Arl/+ mice are lost in utero. 
 
The recently identified axonemal dynein mutation in Arl may play a part in the 
breeding problems and embryonic loss seen in Arl mice, however, due to time 
constraints it was not possible to investigate this in detail.  Nevertheless, it was 
important to establish whether this axonemal mutation was indeed present in the Arl 
colony used in this project and although it was not practical to re-genotype the entire 
colony, a random selection of samples already used in this project was tested to 
determine the presence of the mutation. 
 
As shown in Figure 6, the axonemal mutation is present in some samples, but not all, 
suggesting that the axonemal and cytoplasmic dynein mutations in Arl are able to 
segregate and have randomly done so in some of the mice that were used in this project. 
 
III.3 Dynein heavy chain protein   
 
To investigate whether the Arl mutation had any effect on the levels of dynein heavy 
chain protein in tissue samples, the brains of six mice (3 wildtype and 3 Arl/+) were  
 
  
 
 
 
 
 
 
 
 
Figure 6.  Cytoplasmic and axonemal dynein genotypes of a selection of mice used during 
the project. 
Tissue from a sample of mice used during this project were genotyped for both the Arl mutation 
in cytoplasmic dynein, and the axonemal dynein mutation to identify whether all Arl mice 
contain the axonemal dynein mutation, or if the mutations can segregate.  Samples 1-3 are Arl/+ 
and contain the axonemal dynein mutation.  Samples 4 and 5 are Arl/+, but do not contain the 
axonemal dynein mutation. 
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dissected, homogenised in PBS
-
 and 5µg of each analysed on a 4% SDS PAGE, with  
α-tubulin used as an internal loading control (Figure 7 A). 
 
This was repeated using spinal cord tissue from six mice (as before, 3 wildtype and 3 
Arl/+) which was homogenised and 5µg loaded onto a 4-12% gradient gel (Figure 7 B). 
Analysis of the proteins by western blotting showed no significant difference in the 
amount of DHC in Arl/+ brain tissue or spinal cord tissue compared to wildtype 
littermates.  This suggests that the Arl mutation does not affect the transcription or 
translation, or stability of the DHC protein. 
 
III.4 Integrity of the dynein complex 
 
The dynein complex is composed of two homodimerised heavy chains associated with 
a number of intermediate, light intermediate and light chains to form a fully functioning 
dynein motor protein.  Despite the Arl mutation not being located within the region of 
homodimerisation of the heavy chains, or the areas of association of the accessory 
chains, it could, however, interfere with the stability of the complex causing a 
perturbation to its function.   
 
To investigate this, sucrose density gradient centrifugation was used to see if the 
complex of dynein chains was affected by the Arl mutation.  Brain tissue from wildtype 
and Arl/+ mice was homogenised in PBS
- 
and 2 mg of protein loaded onto 5-25% 
continuous sucrose density gradients and centrifuged at 303,800 x gmax for 4 hr.  
Dynein chains that are associated in the complex would sediment together at 
approximately 20S, but any dynein not in the complex would sediment in much less 
dense fractions as it is “free” from the complex. 
 
Equal fractions were removed from the gradients and analysed by SDS PAGE on 4% 
and 10% gels and western blotting to see if the sedimentation of the dynein chains was 
altered by the Arl mutation.  Heavy chain and intermediate chain were labelled for as 
the mutation is contained within heavy chain, and intermediate chain is the least stable 
component of the complex (King 2009) and therefore the most likely to be affected by 
any disturbance to the complex.  Despite this experiment using adult brain tissue, if the  
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Figure 7.  Quantification of DHC in brain and spinal cord tissue from WT and Arl/+ mice. 
A. Brain tissue from 3 WT and Arl/+ mice was homogenised in PBS- and 5µg of total protein 
loaded onto a 4% SDS PAGE, probed for DHC (1/200), with α-tubulin (1/1000) used as an 
internal loading control.   
B. Spinal cord tissue from 3 WT and and Arl/+ mice was homogenised in PBS- and 5µg of total 
protein loaded onto a 4% SDS PAGE, probed for DHC (1/200), with α-tubulin (1/1000) used as 
an internal loading control.   
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Arl mutation affected integrity of the complex, it would be expected that this would still 
be evident from the WB as the population of Arl homodimers is likely to make up 
approx. ¼ of the total heterozygous dynein sample.  As can be seen from Figure 8, 
there is no difference in the distribution pattern of either the heavy chains or 
intermediate chains, suggesting that the integrity of the dynein complex is not affected 
by the mutation.   
 
III.5 Purifying the dynein complex for analysis of its function 
 
As the dynein heavy chain is too large to practicably clone and express (~530kDa, 
~4,500kb), purification of the complex from tissue was deemed to be the best way to 
obtain the protein for use in functionality assays (such as microtubule gliding assays).  
Dynein complex from wildtype and Arl/+ was isolated to allow comparison of their 
function. 
 
Brain tissue from approximately 35 mice of each genotype (WT and Arl/+) was 
collected and pooled together.  This was homogenised and centrifugation steps used to 
purify the protein, with MT binding and centrifugation through a 20% and then 10% 
sucrose cushion and then release from the MTs with excess ATP.  Pelleting of the MTs 
was used to isolate the MT based motor proteins (dynein and kinesin).  This was then 
further purified on a 5-20% continuous sucrose density gradient to separate the motor 
proteins and equal fractions of the gradient were collected.  These fractions were 
analysed by SDS PAGE on 4-20% gradient gels and coomassie staining and western 
blots were performed to identify the proteins in the fractions and which fraction 
contained the greatest amount of dynein complex for use in functionality assays.  
Samples from the supernatant of the sucrose cushions used in the purification were also 
analysed to estimate the efficiency of the MT binding dependent purification in these 
steps. 
 
Despite there being a greater starting amount of total brain tissue in the Arl/+ 
purification (~20 g of Arl/+ v ~16 g wildtype), more dynein is apparent in the 
supernatant of the 20% cushion from the wildtype sample than the Arl/+ (Figure 9).  
This would suggest that a greater amount of the wildtype dynein did not bind to MTs 
and was therefore unable to sediment through the sucrose cushion than that in the Arl/+  
  
 
 
 
 
 
 
Figure 8.  Western blot of sucrose density gradient  
2 mg of tissue homogenate from WT and Arl/+ was loaded onto a 5-25% sucrose density gradient and 
centrifuged for 4 hr at 50,000 rpm (~303,800 x gmax).  9 equal fractions were removed and run on 4% and 
10% gels and labelled for DHC (1/200) and DIC (1/1000).  No difference in distribution between 
genotypes is seen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
A. Wildtype 
 
 
 
Figure 9.  Western blots of WT and Arl/+ dynein complex from dynein isolation. 
Brain tissue from approximately 35 mice was collected and pooled together.  This was homogenised and 
centrifugation steps used to purify the protein, with MT binding and centrifugation through a 20% and 
then 10% sucrose cushion and then release from the MTs with excess ATP.  This was then further 
purified on a 5-20% continuous sucrose density gradient to separate the motor proteins and 12 equal 
fractions of the gradient were collected.  These fractions were analysed by SDS PAGE on 4-20% gradient 
gels and western blots performed to label for DHC, p150, DIC and α-tubulin, and identify which fraction 
contained the greatest amount of dynein complex. A) Western blot from WT protein, B) western blot 
from Arl/+ protein. 
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sample.  It has already been shown in Figure 7 A that there is no difference in the 
amount of dynein protein in brain tissue between wildtype and Arl/+, meaning if there 
was a greater amount of tissue used in Arl/+, then there should have been a greater 
amount of dynein protein than in the wildtype sample.  This suggests that the difference 
in the amount of dynein able to sediment through the sucrose cushions is due to the 
ability of the dynein to bind to the MTs.   
 
It is worth noting that due to the limited amount of Arl/+ tissue available, this 
experiment was performed only once, and is thus a comparison between WT and Arl/+ 
from 35 mice of each genotype on this one occasion.  
 
The dynein complex is confined to fractions 11 and 12 in wildtype, but is seen in 
fractions 10, 11 and 12 in Arl/+.  The reason for dynein being present in fraction 10 in 
the Arl/+ sample is likely to be due to there being a larger amount of dynein present in 
these fractions which has caused it to “bleed” and overflow into fractions either side.  
This blot shows that the greatest amount of dynein is located in fraction 11 of both 
genotypes, with a lesser amount in fraction 12.  This was confirmed by measuring the 
protein concentrations of fractions 11 and 12 of the purified wildtype and Arl/+ dynein 
samples using a BCA kit.  In WT, fractions 11 and 12 were found to be 0.95 mg/ml and 
0.89 mg/ml respectively, and in Arl 1.23 mg/ml and 1.15 mg/ml.  The difference in 
concentrations between the genotypes is accounted for by the differing starting amounts 
of tissue used.  As fraction 11 contained the greatest amount of dynein in both 
genotypes it was therefore used for subsequent experiments. 
 
Having identified which fractions contained the purified dynein complex, it was 
important to establish the purity of these samples.  To do this the samples were run on 
4-20% gradient gel and coomassie stained to identify all the proteins present in each 
fraction (Figure 10).  In the main fractions containing dynein (11 and 12) the subunits 
of the dynein complex can be identified as well as dynactin and a small amount of 
tubulin.  No other major bands that do not correspond with a dynein subunit appear to 
be present, suggesting that fractions 11 and 12 contain relatively pure dynein and are 
indeed suitable to use for experiments to investigate its function. 
 
 
  
 
 
 
  
Figure 10.  Coomassie gels of WT and Arl/+ dynein complex from dynein isolation. 
Brain tissue from approximately 35 mice was collected and pooled together.  This was 
homogenised and centrifugation steps used to purify the protein, with MT binding and 
centrifugation through a 20% and then 10% sucrose cushion and then release from the MTs with 
excess ATP.  This was then further purified on a 5-20% continuous sucrose density gradient to 
separate the motor proteins and 12 equal fractions of the gradient were collected.  These 
fractions were analysed by SDS PAGE on 4-20% gradient gels and coomassie stained to identify 
the proteins present and which fraction contained the greatest amount of dynein complex. A) 
Coomassie gel of WT sample, B) coomassie gel of Arl/+ sample, showing major proteins 
present in each sample. 
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Analysis of dynein function 
III.6 MT Gliding Assay 
 
The dynein samples were used in microtubule gliding assays to try to determine if the 
Arl/+ mutation affected the motility of the dynein.  Microtubule gliding assays have 
previously been used to look at the speed of the dynein motor along MTs using video 
enhanced differential interference contrast (VE-DIC) microscopy.  The wildtype dynein 
sample was used to optimise the system, so that the Arl/+ sample could be measured 
and compared against it. The system requires flow chambers made from glass 
microscope slides and coverslips with two strips of vacuum grease in between to 
separate them, giving chambers of approximately 15-20 µl volumes.  Casein is flowed 
into the flow chambers and incubated to block the glass, coating it and preventing the 
dynein from denaturing upon attachment, the excess is then washed out using motility 
buffer.  Next, the dynein is flowed into the chamber and incubated for at least 5 minutes 
in a humid chamber (to minimise evaporation of buffer from the small volume of the 
flow chamber).  This allows time for the dynein to bind to the casein molecules, then 
short lengths of polymerised MTs are added to the dynein.  The MTs bind to the dynein 
molecules and can be visualised using VE-DIC and the movements recorded and 
measured.  The movement of the MTs is due to the dynein molecules and provides an 
indication of the level and speed of motility produced by the dynein.  As the dynein 
used in this experiment is a comparison of WT with heterozygous, it is important that 
the individual velocities of many MTs are measured.  This allows velocities of the 
different potential dynein populations to be investigated and distinguished between, as 
WT homodimers from the heterozygous dynein sample should have similar velocities 
to those from the WT dynein sample, and so any difference in velocity is likely to be 
due to the populations containing the mutant Arl. 
 
The system proved difficult to optimise in spite of many different improvements being 
made.  As can be seen from Table 3, 16 different conditions were tried, with some 
showing improvements over others, but none providing MT gliding velocities above 
~0.3 µm/sec (Figures 11 A and B).  In published data from this system dynein has 
shown MT gliding velocities of more than 1 µm/sec (Paschal, Shpetner et al. 1987; 
Shimizu, Toyoshima et al. 1995).  Of the conditions used that did produce MT gliding,  
  
File no Conditions Movement 
Av. Velocity 
(um/sec) 
1 
2x dyn dilution + motility buffer + 0.5mg/ml casein + 100uM taxol + 1mM 
DTT + ATP 1mM MTs bound, but only 1-2 MTs moving v slowly 0.110012963 
2 
2x dyn dilution + motility buffer + 0.5mg/ml casein + 100uM taxol + 1mM 
DTT + 1mM ATP + 0.03% NP40 Fewer MTs bound, fewer than (1). Similar level of movement 0.105242 
3 
10x dyn dilution + motility buffer + 0.5mg/ml casein + 100uM taxol + 1mM 
DTT + ATP 1mM + 0.03% NP40 More MTs bound, greater no of MTs moving 0.357994074 
4 
10x dyn dilution + motility buffer + 0.5mg/ml casein + 100uM taxol + 1mM 
DTT + 4mM ATP +  0.03% NP40 Increased ATP=10x fewer MTs bound. Less movement 0.209417778 
5 
10x dyn dilution + motility buffer + 0.5mg/ml casein +100uM taxol + 1mM 
DTT + 0.2mM ATP + 0.03% NP40 
Greatly decreased ATP= similar no of MTs as with 4mM ATP, some 
movement 0.230471667 
6 
10x dyn dilution + motility buffer + 0.5mg/ml casein + 100uM taxol + 1mM 
DTT + 1mM ATP + 0.03% NP40 
Extra MTs added on top of first layer of MTs and dyn. More MTs bound and 
more movement  0.342031667 
7 
10x dyn dilution + motility buffer + 0.5mg/ml casein + 100uM taxol + 1mM 
DTT + 4mM ATP + 0.03% NP40 
Same conditions, with extra MTs added, but less ATP= same amount of 
MTs bound, but less movement 0.21023 
8 
2x dyn dilution + BRB80 buffer + 0.5mg/ml casein + 100uM taxol + 1mM DTT 
+ 1mM ATP 
Different ionic strength of buffer, still see MT binding. Higher dyn conc 
(2x). Some MTs bound, lot of MT waving, but little movement 0.124198571 
9 
2x dyn dilution + BRB80 buffer + 0.5mg/ml casein + 100uM taxol + 1mM DTT 
+ 4mM ATP + 0.03% NP40 A lot more MTs bound than with 10x dyn dil. Greater no of MTs moving 0.217337368 
10 
Undil. dyn + BRB80 buffer + 0.5mg/ml casein + 100uM taxol + 1mM DTT + 
4mM ATP + 0.03% NP40 + GCO 
Addition of oxygen scavenger system + increased ATP conc. Lots of MTs 
bound, but v little movement 0.146063333 
11 
10x dyn dil. + 0.03% NP40 + 0.5mg/ml casein + 100 uM taxol + 1mM DTT + 
1mM ATP + p150 ab 
MTs bound by addition of p150 antibody. Many more MTs bound, with 
some movement 0.21936 
12 
10x dyn dil. + 0.03% NP40 + 0.5mg/ml casein + 100 uM taxol + 4mM DTT + 
1mM ATP + p150 ab Increased ATP to 4mM, same MT binding, but decreased movement 0.265495714 
13 
2x dyn dil. + 0.03% NP40 + 0.5mg/ml casein + 100 uM taxol + 4mM DTT + 
1mM ATP + DIC ab DIC antibody= lots of MTs bound, but little movement 0.129905 
14 
10x dyn dil. + 0.03% NP40 + 0.5mg/ml casein + 100 uM taxol + 4mM DTT + 
1mM ATP + DIC ab Less dyn= similar amount of MTs bound, slightly more movement 0.218267143 
15 
10x dyn dil. + 0.03% NP40 + 0.5mg/ml casein + 100 uM taxol + 4mM DTT + 
1mM ATP + DIC ab 
Same conditions, but extra MTs added ontop of denatured protein- more 
movement 0.2629145 
16 
10x dyn dil. + 0.03% NP40 + 0.5mg/ml casein + 100 uM taxol + 4mM DTT + 
1mM ATP + p150 ab 
Same conditions, but extra MTs added ontop of denatured protein- more 
movement than with 2x dyn dil and w/o extra MTs added 0.27544 
Table 3.  Motility assay conditions. 
Table giving details of motility assay conditions used, what effect they had and the resulting average motility speeds identified.
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 Figure 11.  Graphs showing average motility speeds from MT gliding assays 
A) Graph of motility speeds from MT gliding assays, grouped by assay conditions used, either 
motility buffer, with varying dynein concentrations and ATP concentrations; or BRB80 
buffer, with varying ATP concentration; or motility buffer with either anti-p150 (1/10) or 
anti-DIC (1/10) antibodies used to bind dynein to coverslip.  Numbers below the graph 
relate to assay condition used (See table 1). 
B) Graph of motility speeds in order of motility speed achieved, from greatest speed to lowest.  
See table 1 for details of assay conditions used. 
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only a very small proportion of MTs were seen to be moving (~1/10
th
 of the total 
number of MTs visible), far fewer than would be expected. 
 
Despite this system having been used by other groups to measure the motility of 
dynein, it has generally used either recombinant dynein, meaning the samples were of 
extremely high purity, or dynein purified from bovine or porcine brain tissue.  Using 
dynein purified from multiple murine brains, by means of protocols designed to purify 
dynein from bovine or porcine tissue may have affected the resulting motility. 
 
As the gliding assay could not be optimised using wildtype dynein and as the protocol 
required such a large amount of brain tissue to obtain the purified dynein, and with the 
number of Arl/+ mice limited due to their poor breeding, it was concluded that only 
limited data could be obtained from this experiment.  It was decided that the Arl/+ mice 
would be used to purify dynein, but that it would be better used to check other aspects 
of the dynein function, such as MT binding and ATPase assays. 
 
III.7 ATPase Assay 
 
To investigate whether the Arl mutation had an affect on the ATPase function of the 
motor, the MT dependent spectrophotometric ATP/NADH coupled assay was used.  
This reaction is based on the conversion of phosphoenolpyruvate (PEP) to pyruvate by 
pyruvate kinase (PK) coupled to the conversion of pyruvate to lactate by lactate 
dehydrogenase (LDH).  The second part of the reaction requires NADH which is 
oxidised to NAD
+
.  NADH absorbs strongly at 340 nm, but NAD
+
 does not, so the 
oxidisation of NADH can be followed by monitoring the absorbance at 340 nm.  The 
decrease in OD340 can then be converted into ATPase activity where 1 molecule of 
NADH oxidised to NAD
+
 corresponds to the production of 1 molecule of ADP by the 
motor ATPase (Huang and Hackney 1994). 
 
 
 
 
 
 
  
 
Figure 12.  Summary of ATP/NADH coupled assay.  (Adapted from (Huang and Hackney 1994) 
 
To optimise the reaction and ensure that it worked, the wildtype purified dynein protein 
was used. A baseline reading was obtained using only reaction buffer (no dynein or 
MTs), then the ATPase activity of dynein without MTs was measured to estimate any 
non-MT dependent activity that may be present.  The reaction was then conducted, 
initially using 20 µg of dynein and 25 µg of MTs.   No rates of reaction at OD340 were 
observed, indicating that the reaction was not occurring as expected.  The ATPase 
activity of dynein is MT dependent (Huang and Hackney 1994), and so the amount of 
MTs and dynein added to the reaction was varied, using 20 µg of dynein and 50 µg of 
MTs; 20 µg of dynein and 75 µg of MTs.  Then, in case the amount of dynein being 
used was too small for the reaction volume, 40 µg of dynein and 50 µg of MTs, then 40 
µg of dynein and 100 µg of MTs were tried.  However, this had no effect on the assay 
and no rates were recorded using any of the combinations.   
 
Availability of both the purified dynein and the purchased tubulin were limiting factors 
in being able to optimise this assay as large volumes of both were required, restricting 
the number of times the assay could be repeated to allow optimisation.  Another 
difficulty was the absence of a suitable positive control to ensure that the assay system 
was working correctly.  Because of these factors, the ATPase activity of the wildtype 
purified dynein could not be measured.  
 
III.8 MT Binding Assay 
 
Despite being unable to measure the ATPase activity of the dynein, the binding to MTs 
can be determined by incubating dynein with MTs and centrifuging through a sucrose 
cushion.  Only dynein bound to MTs is dense enough to sediment through the cushion
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and pellet at the bottom of the tube, thus giving an indication of the efficiency of the 
binding of the dynein to MTs.   
 
When tested with WT purified dynein this method worked well, so the Arl dynein 
sample was used to compare against the wildtype.  Using the pooled dynein samples, 
the pull-down was repeated three times for each genotype.  20 µg of dynein sample was 
incubated for 30 min at 37
o
C with 50 µg of polymerised MTs, then layered over a 20% 
sucrose cushion and centrifuged for 40 min at 30,000 rpm (77,100 x gmax).  The top 
supernatant fraction was removed, then the cushion fraction.  The pellet was washed 
and re-centrifuged and the pellet re-suspended and collected.  Samples from each 
fraction were run on 4-12% gradient gels and blotted for DHC, DIC and α-tubulin.   
 
As can be seen from Figure 13 A, the greatest amount of dynein pulled down, relative 
to the amount of MTs, is in the Arl sample, suggesting that the binding of dynein to 
MTs is stronger or more efficient in Arl than WT.  To quantify this, the dynein signal 
was measured and compared against the tubulin signal for each sample.  By comparing 
the amount of dynein pelleted against the amount of tubulin pelleted, it disregarded any 
differences in the efficiency of tubulin polymerisation into MTs and therefore the total 
starting amount of MTs that were available to bind dynein.   
 
Using the MT binding of WT as a reference, the binding of Arl was compared against 
it.  As shown in Figure 13 B, the MT binding of the dynein is significantly greater in 
Arl than in WT (p=0.03), suggesting that the Arl mutation increases the affinity of 
dynein for MTs. 
 
This data, together with the larger amount of dynein seen after centrifugation through 
sucrose cushions during the dynein purification suggests that the Arl mutation increases 
the binding of dynein to MTs compared to WT dynein.   
 
III.9 Discussion 
 
The recently identified axonemal dynein mutation in Arl may be involved in the 
reduced breeding and embryonic loss of Arl seen in this colony.  Axonemal dynein type 
11 is mutated and this is known to be involved in positioning of organs during
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 Figure 13.  Binding of dynein to MTs in WT and Arl/+ 
A) Purified dynein complex was incubated with polymerised MTs and layered over a 20% 
sucrose cushion, centrifuged and supernatant (S), cushion (C) and pellet (P) fractions 
collected for both WT and Arl/+.  Samples were run on a 4-12% gradient gel, western 
blotted and labelled for DHC, DIC and α-tubulin.  A range of exposures were taken, but 
only those not overexposed were used for quantification purposes.  The tubulin in this figure 
is to demonstrate the relative amounts of dynein to tubulin only, and the tubulin signal was 
not used for quantification. 
B) Relative binding of DIC to α-tubulin in Arl/+ was compared to WT reference.  3 samples of 
each genotype were measured. 
DHC 
 
 
 
 
 
DIC 
 
α-tubulin 
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development.  When crossed with iv mice (a model for the human condition, situs 
invertus), the phenotype similar to that of iv/iv mice is seen.  In human situs inversus, a 
common underlying cause is PCD which results in non-functioning spermatozoa in 
males.  Therefore, further investigations into the effects of the axonemal dynein 
mutation on Arl mice are required and should include analysis of spermatozoa function 
to determine whether this is the cause of the reduced breeding seen in Arl mice. 
 
As details of this mutation were only recently made available, it was out of the scope of 
this project to investigate in detail the possible involvement in the Arl phenotype.  
However, because of the specific roles played by cytoplasmic and axonemal dynein, it 
is unlikely that the axonemal mutation would affect the cytoplasmic dynein functions 
investigated in this thesis. 
 
The Arl mutation is located in an area of unknown function, N-terminal to the motor 
domain, but C-terminal to the sites of both homodimerisation and accessory chain 
binding.  Therefore, it was unlikely that the integrity of the complex would be 
perturbed by the mutation.  However, as the function of the heavy chain region 
containing the mutation is unknown, it was possible any structural change caused by 
the mutation could affect the heavy chain and possibly have a knock on effect on the 
structure of the complex.  Although it was important to check for any effects on the 
complex integrity, none were identified.  This suggests that Arl does not affect the 
complex and also indicates that the area of unknown function is not involved in 
maintaining the structure or composition of the complex. 
 
The amount of dynein recovered during the purification suggests a difference in the 
amount of dynein able to sediment through the sucrose cushions (Figure 9), possibly 
due to a difference in affinity for MTs.  However, the samples had been incubated with 
AMP.PNP, a non-hydrolysable analogue of ATP, so the dynein complex would not 
have been in its maximal MT binding conformation.  That a greater amount of Arl/+ 
dynein is seen in the pellet, having centrifuged through the sucrose cushion compared 
to WT, suggests that even in low MT binding state, the Arl dynein may still bind MTs 
more than WT dynein. 
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As shown in Figure 9, all the components of the dynein complex are present after 
purification, in both WT and Arl/+ samples.  However, despite all the different 
conditions tried, the purified dynein was unable to move a significant proportion of 
short lengths of MTs, or at a sufficient velocity, compared to published data.  No 
dynein positive control was available, however, the kinesin positive control was used to 
initially set up the system and MT gliding was identified, indicating that none of the 
reagents involved were at fault (for example, the ATP which can become unstable and 
become hydrolysed to ADP).  This suggests that the purified dynein may not have been 
functioning fully.  This is most likely as the dynein used in the gliding assay was WT, 
and so there should be no other reason for it to be unable to move the MTs.  The 
optimisation of the system was conducted on separate occasions, each time with freshly 
prepared dynein sample, so an isolated problem with one sample cannot be the cause. 
 
The dynein purification is based on a protocol first established for purifying dynein 
from either bovine or porcine brain.  It has not previously been used to purify dynein 
from multiple murine brains, and this difference may be where the problem lies.  
During the purification procedure, the activity of the dynein may be compromised, but 
the integrity of the complex maintained.   
 
This is supported by the lack of ATPase activity recorded from the WT dynein sample.  
Again, no suitable dynein positive control was available to ensure the assay system was 
working, and there may have been an issue with the assay that prevented it from 
identifying enzyme activity, or the assay may not have been sensitive enough, with 
ATPase levels too small to be detected.  However, this seems unlikely as it is a well 
established and published protocol, which has successfully been used to measure the 
basal ATPase activity of dynein, without MTs.  Once stimulated by MT binding, 
ATPase activity has been shown to increase approximately sevenfold (King and 
Schroer 2000).  Even if the assay was unable to detect a small ATPase activity before 
MT stimulation, it seems unlikely that it would also not be sensitive enough to detect an 
activity seven times greater.  Together, it suggests that there was no ATPase activity to 
detect, supporting the theory that the protocol for purifying the dynein sample affects 
its ATPase activity.   
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A positive control would need to be identified to ensure the assay was properly 
functioning and to identify the level of sensitivity to then definitively determine 
whether the dynein sample maintained any ATPase activity.  Based on this, possible 
alterations to the purification protocol could be investigated with the aim of resolving 
the loss of ATPase activity.  Once this problem was rectified, the Arl/+ dynein could be 
tested to identify any difference in ATPase activity compared to WT. 
 
The possible lack of ATPase activity does not appear to affect the MT binding of either 
the WT or Arl/+ dynein samples.  Both genotypes show binding of MTs, but with 
greater levels identified in Arl/+ compared to WT, suggesting that the Arl mutation 
may cause the dynein to have a greater affinity for MTs compared to WT. 
 
The binding of dynein to MTs is dictated by the affinity state of the MTBD, and this 
affinity is linked to the binding, hydrolysis and release of ADP/ATP in the AAA 
domains of the motor ring.  As discussed in chapter I, the difficulty of the large distance 
between the sites of ATP hydrolysis and MT binding is thought to be overcome by 
conformational changes around the AAA domains which change the registry of the 
coiled-coils of the stalk.  This change in relative position of the coiled-coils is thought 
to regulate the affinity of the MTBD for MTs.   
 
The proposed linker domain below the motor head is suggested to mediate the swing of 
the powerstroke after ATP hydrolysis.  As the Arl mutation is located just C-terminal to 
the proposed location of the linker domain, it may affect the powerstroke.  The linker 
domain is suggested to be close to the first AAA domain, one of the main sites of ATP 
hydrolysis, so if Arl caused an unknown structural change that affects the flexibility of 
the linker, it could have a knock-on effect of disrupting the conformational change 
around the ring structure, in the coiled-coil and ultimately in the MTBD.  As the Arl/+ 
dynein appears to increase the affinity of dynein for MTs compared to WT, this would 
suggest that a conformational change causes the MTBD to be maintained in a higher 
affinity conformation, compared to WT. 
 
This proposed mechanism relies on the ATPase activity being established, so the assay 
is extremely important in identifying if the Arl mutation affects nucleotide binding 
and/or hydrolysis.  It is also vital to establish whether a change in structure is brought 
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about by the mutation.  As the location of the Arl mutation is currently of unknown 
structure and function, cloning of the area, expression and crystallisation to allow the 
structure of both Arl and WT to be determined and compared by x-ray crystallography 
is important in establishing the effect of the Arl mutation on the heavy chain.   
 
Current work has included isolating mRNA from Arl/+ brain tissue, reverse 
transcription PCR to obtain cDNA of both Arl and WT, and PCR with primers specific 
for an area of the heavy chain containing the mutation (Pfam-B 8363 region consisting 
of residues 1032-1282).  This has been cloned into a tagged expression vector, but 
further work will include expression of the protein, establishing its solubility and 
purifying using the tag. Crystal trials will then be set up, and any resulting crystals used 
to obtain diffraction patterns, from which the structures of the Arl and WT can be 
established.  This information will allow Arl and WT structures to be compared and 
identify if the mutation causes significant structural perturbation.   
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Chapter IV 
 
 
INVESTIGATING THE EFFECT OF THE ARL MUTATION ON CARGO 
TRANSPORT 
 
 
IV.1 Introduction 
 
As discussed in Chapter I, intracellular organelle transport is essential for a large 
number of cellular processes.  The ability of a motor to transport its cargo provides an 
indication of the functioning of that motor. 
 
As shown in Chapter III, in vitro assays of dynein function have proved difficult to 
obtain useful data from.  An alternative method is to track the movements of cargos in 
cultured cells to investigate the effect of the Arl mutation on the cargo transport 
functions of cytoplasmic dynein. 
 
In mammalian cells, the Golgi is positioned near the centrosome in a perinuclear 
distribution.  The membranes require dynein and kinesin to maintain their position, as 
loss of dynein activity causes dispersal away from the centrosome and loss of kinesin 
causes compaction around the centrosome.  Dysfunction in Golgi localisation can 
severely affect the organisation of the secretory pathway.  This makes the Golgi an 
ideal cargo to investigate the effect of Arl on dynein’s ability to transport a major and 
important cargo. 
 
Endocytosis is an important mechanism in mammalian cells that involves 
internalisation of extracellular nutrients, regulation of cell surface receptor expression 
and antigen presentation for example.  The best characterised mechanism of 
endocytosis is clathrin dependent receptor mediated, which is used by a large number 
of extracellular ligands that have different cell surface receptors, such as EGF, 
transferrin, antibodies and LDL.  The binding and internalisation of the ligand-receptor 
complex into endosomes results in their trafficking through the endosomal pathway, 
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either for degradation (e.g. EGF) or recycling (e.g. transferrin) (Benmerah and Lamaze 
2007; Parkar, Akpa et al. 2009).   
 
Dynein is responsible for the trafficking of endosomes through the degradative 
endosomal pathway to the lysosomes and so tracking of EGF positive endosomes 
provides a way of investigating dynein’s ability to transport an important cargo. 
 
Mitochondria are translocated along MTs by members of the kinesin family and 
cytoplasmic dynein, as well as actin tracks driven most likely by myosin V.  Their 
transport is modulated in response to physiological signals and local energy 
requirements.  For example, in active neuronal growth cones, mitochondria move into 
them and become stationary, however, when growth cone activity is lower, the 
mitochondria switch to retrograde movement (Frederick and Shaw 2007). 
 
Dysfunctional mitochondria are moved towards the cell body to be repaired by fusion 
with healthy mitochondria, or for degradation by mitophagy.  In the cell body 
mitochondrial fission produces healthy mitochondria that are the correct size which are 
then transported down axons towards the synapses (Frederick and Shaw 2007). 
 
So there are a number of situations where mitochondrial movement is required and 
retrograde transport is therefore extremely important.  The importance of mitochondrial 
transport makes them an ideal cargo to utilise in the investigation of dynein-dependent 
transport. 
 
IV.2  In vitro cell system 
 
MEFs are an excellent model system for studying cellular function.  Primary MEFs are 
easily cultured from E13 embryos and can be passaged a number of times without the 
need for immortalisation.  However, because MEFs are derived from mesenchymal 
tissue (derived from all three germ layers), it means that gastrulation needs to have 
occurred for embryos to be used to culture MEFs from.  As Arl/Arl embryos are not 
viable after E10 (during embryo gastrulation), it means that MEFs cannot be cultured 
from Arl/Arl embryos.  WT E10 embryos were tested to see if any cell culture could be 
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established from such an early stage, but this was unsuccessful, meaning that cellular 
function of Arl/Arl cannot be investigated in vitro. 
 
 
IV.3 Golgi Reassembly 
 
Cytoplasmic dynein is involved in the maintenance of the location of Golgi within the 
cell.  Previously it has been shown that disruption of the MTs causes the dispersion of 
Golgi throughout the cell, as the dynein is unable to maintain its location (Hafezparast, 
Klocke et al. 2003).  Once the MTs are able to re-polymerise, the dynein is responsible 
for re-assembling the Golgi.  Because of this, the Golgi is useful in studying the ability 
of dynein to transport its cargo. 
 
The experiment was conducted in MEFs as they are a well characterised and robust 
model cell system.  This experiment has been extensively studied, particularly in Loa 
cells (Hafezparast, Klocke et al. 2003), so was useful to compare against the severity of 
the Arl mutation.  Arl and Loa mice were crossed, and the resulting embryos were used 
to derive primary MEF cultures of all 4 possible genotypes (WT, Arl/+, +/Loa and 
Arl/Loa). 
 
Normally in cells, Golgi is maintained in a perinuclear region as shown by the untreated 
cells in Figure 14.  In this experiment the cells were treated with cold and nocodazole 
(NZ) to depolymerise the MTs, resulting in the Golgi fragmenting throughout the cell, 
the NZ was washed out and the cells allowed to recover over a timecourse of 50 min.  
As shown by the WT cells in Figure 14, at 0 min, straight after the NZ has been washed 
out, the Golgi is fragmented around the cell, but by 30 min the Golgi has reassembled 
back into stacks of cisternae. 
 
However, in the cells containing dynein mutations, the re-assembly of the Golgi is 
incomplete at 30 min, and it is not until 50 min that the dynein has transported the 
Golgi fragments back to form stacks around the nucleus.  The compound heterozygotes 
are the most severely affected, with the reassembly far from complete by 30 min.  The 
Golgi re-assembly is not rescued in the compound heterozygotes, demonstrating the Arl 
and Loa mutations do not show complementation, suggesting they may be allelic.  The  
  
 
 
 
Figure 14.  Golgi reassembly after disruption with nocodazole in WT, Loa/+, Arl/+ and Arl/Loa MEFs. 
MEFS were treated with cold (4
o
C) for 30 min and nocodazole for 3 hr, washed and then allowed to recover at 37
o
C for the times indicated.  Golgi 
here is shown in red and nuclei in blue (DAPI).  The scale bar here represents 30μm, n=10 
 
Wildtype     Loa/+      Arl/+     Arl/Loa 
Untreated 
 
 
 
 
 
0 min 
 
 
 
 
 
30 min 
 
 
 
 
 
50 min 
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reassembly of the Golgi in the Arl cells is less complete than in the Loa cells, 
suggesting the Arl mutation impairs the function of dynein more so than Loa.  By 50 
min the recovery is more advanced, although not complete in the cells containing the 
dynein mutations.  This data agrees with data previously obtained from Loa and 
indicates that the Arl mutation also impairs dynein’s ability to transport Golgi after it 
has been fragmented around the cell.   
 
To quantify this data, Image J was used to count the total number of Golgi fragments 
and measure the total area of Golgi in each cell.  This was used to calculate ratios of the 
number of fragments against the total area and used to compare between the genotypes 
at each timepoint (n=10).  A number of methods for analysis of this data were 
investigated, such as comparing total Golgi signal or number of remaining fragments 
between cells of each genotype.  However, the cells analysed were of a range of sizes, 
meaning that direct comparison of total Golgi signal or number of fragments were not 
suitable methods of comparison.  By calculating a ratio of the number of Golgi 
fragments against the total signal, the differences in the sizes of the cells measured was 
not a factor, and comparisons of the ratios could be used to determine the degree of 
reassembly in the cells of different genotypes. 
 
While full reassembly of the Golgi is complete by 30 min in WT (Figures 15 A and 15 
B), Golgi in cells containing mutant dynein (both Arl and Loa) is not completely 
reassembled, even after 50 min of recovery.  In Loa/+ the Golgi is nearing complete 
recovery, compared to untreated control cells (p=0.013), however, in Arl/+ cells the 
recovery is less complete by this stage (p=0.001).  This suggests that the Arl mutation 
impairs the transport of Golgi more severely than Loa.   
 
IV.4 Fixed Cell EGF Trafficking  
 
Dynein function is well established in the trafficking of epidermal growth factor (EGF), 
so it is useful in investigating the effect of the Arl mutation on cytoplasmic dynein’s 
role in the endocytic trafficking pathway. 
 
MEFs were starved for 2 hr, then pulsed for 10 min with Alexa-fluor 555 conjugated 
EGF, washed twice and chased for 50 min.  As shown in Figure 16, after the 10 min  
  
 
 
 
 
A)  
 
 
Mann-Whitney Test   
Comparison p value Significance 
WT-C  → WT-0min 0.0002 *** 
WT-C  → WT-30min 0.1903 ns 
WT-C  → WT-50min 0.0599 ns 
Loa/+-C → Loa/+-0min 0.0002 *** 
Loa/+-C → Loa/+-30min 0.0008 *** 
Loa/+-C → Loa/+-50min 0.0127 * 
Arl/+-C → Arl/+-0min 0.0001 *** 
Arl/+-C → Arl/+-30min 0.0001 *** 
Arl/+-C → Arl/+-50min 0.0013 ** 
Arl/Loa-C → Arl/Loa-0min 0.0003 *** 
Arl/Loa-C → Arl/Loa-30min 0.0001 *** 
Arl/Loa-C → Arl/Loa-50min 0.0081 ** 
 
B) 
 
Figure 15.  Quantification of Golgi reassembly after disruption with nocodazole in WT, Loa/+, Arl/+ 
and Arl/Loa MEFs. 
A) Using the Image J program the total number of discrete spots and the total area of Golgi complex were 
measured, to calculate the ratio of spots/total area per cell in untreated, control cells and at 0 minute, 30 
minute and 50 minute timepoints of recovery after nocodazole wash out. 
B) Table of p values showing levels of significance in differences in recovery of Golgi between genotypes 
at different timepoints.  n=10 cells 
 
 
 
  
 
 
Figure 16.  Endosomal trafficking chase of Alexa Fluor 555 conjugated EGF in wildtype, Loa/+, Arl/+ and Arl/Loa MEFs 
MEFs were pulsed with EGF for 10 minutes and chased at 37
o
C for the times indicated. EGF is shown in pseudo-coloured inverted greyscale, the 
cytoskeleton (α-tubulin) in green and nuclei in blue (DAPI). The scale bar represents 30μm. 
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pulse, most of the EGF-positive endosomes are accumulated around the cell periphery, 
where it has been internalised.  After 50 min, in WT cells there are far fewer EGF-
positive endosomes suggesting the majority of the EGF has been trafficked through the 
endosomal pathway towards the lysosomes for degradation.  In the cells containing the 
Loa and Arl mutations, there are a greater number of EGF-positive endosomes 
remaining after 50 min compared to WT, with the compound heterozygotes containing 
the most.   
 
To quantify this data Image J was used to count the total number of EGF-positive 
endosomes in each cell at each timepoint.  From Figure 17 it can be seen that after 50 
min there are significantly more EGF-positive endosomes remaining in the cells 
containing either the Loa or Arl or both mutations, compared to WT (p=0.023, 0.011 
and <0.001 respectively).  These endosomes are yet to reach the lysosomes to be 
degraded, suggesting that their transport has been delayed compared to WT due to the 
mutations in cytoplasmic dynein (n=15 cells).  
 
Together with the data from the Golgi reassembly this indicates that the Loa and Arl 
mutations do not show complementation and thus suggests they may be allelic.  In 
addition, a number of Arl/Loa crosses were allowed to proceed to full term and 
littering.  Of 17 litters, comprising 89 pups, no compound heterozygotes were detected, 
supporting the notion that the Loa and Arl mutations do not complement each other and 
thus the two mutations are allelic. 
 
IV.5 Live Cell EGF Trafficking 
 
In order to better understand the delay in EGF trafficking seen in the fixed cell 
experiment, live cell imaging was used which allows the movement of individual 
vesicles to be tracked and analysed. 
 
As the allelism between Loa and Arl had been established through the lack of 
complementation seen in the experiments looking at Golgi reassembly and EGF 
trafficking in fixed cells, and the phenotype of the Arl mutation has been compared to 
that of the Loa mutation, experiments were now only conducted using Arl/+ and WT 
cells. 
  
 
A. 
 
 
 
 
B. 
 
Unpaired t-test   
Comparison p value Significance 
WT 0 min → Loa 0 min 0.8619 ns 
WT 0 min → Arl 0 min 0.9659 ns 
WT 0 min → Arl/Loa 0 min 1.000 ns 
WT 50 min → Loa 50 min 0.0226 * 
WT 50 min → Arl 50 min 0.0106 * 
WT 50 min → Arl/Loa 50 min <0.0001 *** 
 
 
 
Figure 17.  Quantification of number of EGF-positive vesicles remaining in WT, Loa/+, Arl/+ and 
Arl/Loa MEFs after indicated timepoints. 
A. Image J was used to count the number of EGF-positive vesicles remaining in MEFs after 10 
minute EGF pulse and 50 minute chase. n=15 cells. 
B. Table of p values showing level of significance in difference between numbers of EGF-positive 
vesicles in different genotypes at indicated timepoints.   
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MEFs were starved for 2 hr and stimulated with EGF as already described, then filmed 
for 1 min periods at set points in a 30 min timecourse at 1 frame every 2 sec.  An Image 
J plug-in, Particle Tracker (Sbalzarini and Koumoutsakos 2005), was used to track the 
trajectories of the EGF-positive endosomes and this data was used to determine the 
total distance travelled by each endosome over a particular number of frames (Figure 
18 A and 18 B).  This allowed the speed of each endosome to be calculated and 
compared between genotypes.  Figure 19 A shows that there is a significant difference 
in the average speed of the endosomes, with WT moving at a greater speed than Arl/+.  
This explains the delay in endosomes reaching the lysosomes for degradation in the 
fixed cell experiment, as the endosomes are being transported more slowly by Arl/+ 
dynein.  
 
To investigate whether the endosomes behaved differently over the course of their 
transport through the pathway, the trajectories were analysed separately at different 
points throughout the timecourse (1 min, 15 min and 30 min).  As shown by Figure 19 
B, there is a significant difference in the speeds of the Arl endosomes compared to WT 
at each of the timepoints (p= 0.034, 0.012 and 0.019 respectively), but no difference 
between the timepoints in the same genotype.  This suggests that the impairment of 
dynein transport in Arl/+ cells is maintained throughout the endosome transport 
pathway and is not affected by where the endosome is located within the pathway. 
 
IV.6 Transport of Mitochondria 
 
To determine whether the Arl mutation affected dynein-dependent retrograde transport 
of mitochondria, MEFs were grown in coverslip chambers, suitable for live cell 
imaging.  The cells were incubated with 50 nM mitotracker for 30 min, washed and 
then imaged using the FITC channel on the Deltavision pDV live cell imaging 
microscope.  Movies of 1 min length were filmed at 1 frame/2 sec to record the 
movement of the labelled mitochondria (See Figure 20). 
 
To quantify the movement of the mitochondria, the Image J plug-in, ParticleTracker, 
was used to track the trajectories of the movement (n=3 cells).  This was used to 
determine the total distances travelled over each movie and thus the speed at which the 
mitochondria were moving in each genotype.  As seen in Figure 21, the mean speed of  
  
 
 
Figure 18.  Endosomal trafficking of Alexa-555 conjugated EGF in WT and Arl/+ MEFs 
A) Still frames from movies tracking movement of EGF in WT and Arl/+ MEFs.  MEF cells shown using DIC channel and EGF in red.  
B) Image J Particle Tracker plug in used to track the trajectories of EGF-positive endosome movement over duration of movies. 
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B) 
 
Figure 19.  Quantification of speed of endosome movement in WT and Arl/+ MEFs 
A) Trajectories of endosome movements were used to calculate total distance travelled over specified 
frames to give over all average speeds of EGF-positive endosomes in WT and Arl/+ MEFs. 
B) Speeds of EGF-positive endosomes were calculated from movies at specified timepoints throughout 
chase to identify any differences in endosome speed between WT and Arl/+ at different points in the 
endosomal pathway.  n=5 cells (approx. 150 endosomes per cell). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 20.  Still frames from movies showing movement of mitochondria in WT and Arl/+ MEFs. 
MEFs were incubated with 50nM Mitotracker Green FM for 30 min at 37
o
C, replaced with CO2 independent medium and filmed at 1 frame /2 sec.  Arrows track 
movement of individual mitochondrion in each genotype.  Still frames taken from movies at 0, 10 and 20 sec.  Greater distance travelled over timeframe in WT 
compared to Arl/+.  Scale bar = 20µm 
00.00 sec 00.10 sec 00.20 sec 
00.00 sec 00.10 sec 00.20 sec 
Wildtype 
Arl/+ 
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mitochondria is slower in Arl/+ compared to WT, however, this difference is not 
significant (p=0.36). 
 
IV.7  Transport of cargo in motor neurons 
 
MEFs make a robust model cell system, but it is important to identify if similar cargo 
transport delays are also seen in Arl neurons, specifically, motor and sensory neurons.  
To do this, neurons were cultured from E13 embryos.  The neurons can only be 
cultured from E13 embryos as in younger embryos neurogenesis has not progressed 
sufficiently for differentiated neurons to be present.  Neural tissue can be cultured, but 
would need to be directed to differentiation in vitro.  Utilising embryos of ~E13 stage 
of development allows dissection of differentiated neurons, meaning either motor or 
sensory neurons can be dissected and cultured.  As studies using other cytoplasmic 
dynein mutations, such as Loa, Cra1 and Swl have identified differences in motor and 
sensory deficiencies, it is important to determine how these neurons are affected in Arl. 
 
Due to the very low levels of breeding in Arl mice, only one set of embryos were 
obtained for use in neuron culture.  Unfortunately, after the culture of motor neurons 
from this litter of embryos, genotyping revealed that only WT embryos had 
successfully produced neuron cultures.  No further embryos were able to be obtained to 
repeat the culture of motor neurons, or try the culture of sensory neurons.   
 
IV.8 Discussion 
 
Intracellular transport of many organelles is extremely important for proper functioning 
of the cell.  As dynein has been shown to be responsible for retrograde transport in 
cells, any impairment to its function could have a significant impact on its ability to 
transport cargo, which could severely impact the function of the cell. 
 
The effects of Arl on some of dynein’s major cargo show similar phenotypes, with 
differing degrees of significance, except for the movement of mitochondria.  This 
suggests that the effect of Arl on cargo transport may not be specific to particular cargo, 
and so is not a problem with tethering of cargo.  As the location of the mutation is not 
near the N-terminal site of cargo interaction, this is not unexpected.  The decrease in  
  
 
 
  
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
            
 Figure 21.  Graph showing mean mitochondrial speed in WT and Arl/+ MEFs. 
MEFs were incubated with 50nM Mitotracker for 30 min at 37
o
C, then replaced with CO2 
independent media and imaged for 1 min movies at 1 frame/2 sec to record the speed of 
mitochondrial movement. n=3 cells. p= 0.36 using unpaired t-test. 
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cargo transport speeds is more likely to be due to problems with dynein movement 
which results in the slower movement of cargo.   
 
The lack of significant difference in mitochondria speed between WT and Arl/+ may be 
that Arl affects cargo transport of mitochondria differently to other cargos, or the 
measurements could be affected by kinesin transport.  Due to the nature of the MT 
arrays in fibroblasts, it can be difficult to distinguish directionality of cargo moving 
along them.  This is not a problem when looking at uni-directional cargo (such as 
reassembly of disrupted Golgi, or endosomes), but mitochondrial movement is bi-
directional, with dynein transporting in a mainly retrograde direction, and kinesin 
mainly anterogradely.  If some of the mitochondrial measurements were of kinesin 
dependent movement, then this may have affected the measurements.  Because of this, 
it is important for this experiment to be repeated in cells where direction of movement 
along the MTs can be easily determined, such as along neuronal axons.  This would 
allow a direct comparison of dynein dependent mitochondrial movement to be made 
between WT and Arl/+. 
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Chapter V 
 
 
INVESTIGATING THE EFFECT OF THE ARL MUTATION ON THE GOLGI 
APPARATUS AND MITOCHONDRIA USING TRANSMISSION ELECTRON 
MICROSCOPY 
 
 
V.1 Introduction 
 
In order to better understand the effects of the Arl mutation on the Golgi apparatus and 
mitochondria, and identify other possible cellular disruptions caused by the mutation, 
transmission electron microscopy (TEM) was employed.  This method of microscopy 
allows high magnification images to be obtained showing great cellular detail.  TEM 
images are taken of cross sections of either cells or tissue that have been fixed and 
stained with heavy metals.  The differing affinity of structures for these heavy metals 
makes some appear electron-dense (high affinity), while others are electron-weak (low 
affinity), producing the high level of detail. 
 
 
V.2 Ultrastructural Analysis of the Golgi Apparatus 
 
Adult WT and Arl/+ mice were perfusion fixed using gluteraldehyde and 
paraformaldehyde.  The spinal cord was exposed by laminectomy and removed in 
sections and allowed to post-fix for 48 hr, immersed in osmium tetroxide and then 
sequentially dehydrated.  The spinal cord sections were finally embedded in resin, then 
sectioned using a microtome to produce 100 nm transverse sections of spinal cord. 
 
Images of neuronal cells from lumbar spinal cord sections were taken at 1000 x 
magnification to capture detail of the entire cell body, and then higher magnification 
(5,000 and 10,000 x) images obtained greater detail of specific areas of interest within 
the cell.  Lumbar spinal cord was selected as the clenching phenotype in the Arl mouse 
is confined to the hindlimbs, suggesting that any possible neuronal defects are located 
in this area of the spinal cord. 
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Although the reassembly of Golgi after disruption was impaired, as discussed in 
Chapter IV, the untreated control cells did not show any impairment due to the Arl 
mutation.  However, immunocytochemistry cannot detect fine structural defects, only 
larger positioning issues.  Therefore TEM is ideal to check the ultrastructure of the 
Golgi membrane and look for any problems with the organisation of the cisternae. 
 
The lower magnification images (1000 x) were used to check the general amount and 
location of the Golgi in WT and Arl/+ neuronal cells.  In general, the Golgi appeared to 
be of normal structure and location in WT cells, with the stacks of flattened membranes 
mainly near the centre of the cells, around the nucleus.   
 
Using higher magnification (5,000 and 10,000 x) images were taken to look at the 
Golgi in greater detail (Figure 22).  In WT the Golgi appears as would be expected, 
with well structured flattened membranes, often in a semicircular shape.  Vesicles are 
apparent near the trans-Golgi network suggesting that the Golgi is properly functioning 
in processing molecules for transport - likely to be secretory vesicles containing 
neurotransmitters. 
 
In Arl/+ cells, much of the Golgi appears normal, similar to that seen in the WT cells.  
However, as shown in Figure 22, some of the cisternae are very loosely packed, with 
large gaps between the stacks of membrane, suggesting that dynein is unable to 
maintain the normal fine structure.  Such large spaces between the stacks of membranes 
may affect the movement of macromolecules between the cis and trans faces of the 
Golgi network.  This in turn could cause problems with modification and/or labelling of 
proteins received from the rough endoplasmic reticulum (rER), possibly leading to 
incorrectly modified proteins or incorrect secretion.  In neuronal cells these proteins 
could include neurotransmitters, essential for the proper communication between 
neurons. 
 
 
 
 
 
  
 A 
 
  
 
 B 
 
 
 Figure 22.  TEM micrographs showing Golgi structure in WT and Arl/+ cells 
 TEM sections were imaged at 5000x magnification.  Arrows indicate Golgi apparatus. 
A) Typical Golgi apparatus morphology in a WT neuronal cell with closely packed membranes 
B) Typical Golgi apparatus morphology in an Arl/+ neuronal cell, with very loosely packed 
membranes with large gaps.  Scale = 1 µm 
 
80 
 
 
V.3 Ultrastructural Analysis of the Mitochondria 
 
Another major cargo of cytoplasmic dynein is mitochondria, which are required to 
travel large distances, particularly in neurons, from axons to the cell body for recycling 
and degradation.  This retrograde movement is mediated by dynein and therefore may 
be perturbed by the Arl mutation.  Highly polarised cells, such as neurons, are 
particularly sensitive to defects in mitochondrial movement and so are ideal for 
studying the effects of possible transport defects.   
 
To check for possible transport defects, the number of mitochondria in the cell body of 
neuronal cells, imaged at 1000 x magnification, were counted and compared between 
the genotypes of TEM sections.  As can be seen from Figure 23, there is an overall 
trend for a greater number of mitochondria in WT cells compared to Arl/+ cells, 
however this difference is not significant (p=0.2037, n=15). 
 
The greater number of mitochondria present in WT cells compared to Arl/+ cells 
suggests that the transport of mitochondria from axons to the cell body for degradation 
may be slightly impaired in Arl/+ compared to WT, or the rate of degradation of 
mitochondria by autophagy may be increased.  If there is a constant turnover of 
mitochondria, then a decrease in dynein transport, but continued levels of kinesin 
anterograde transport, would have the net effect of decreasing the number of 
mitochondria at the cell body. This difference could also be due to smaller sized 
neurons.   
 
Recent studies in Arl (Bros-Facer, Golding et al. Manuscript in preparation) have 
identified a change in the size of motor neurons, from lumbar spinal cord, towards a 
greater number of smaller neurons, compared to WT.  Smaller neuron size could 
explain fewer mitochondria identified in the cell bodies of these neurons.  To determine 
whether this was the case, the diameter of the soma of the neurons were measured from 
the TEM micrographs, using Image J and compared between WT and Arl/+.  As shown 
in Figure 24, the Arl/+ neuronal soma are significantly smaller in diameter compared to 
WT (p=0.03).  This indicates that the reduced number of mitochondria seen in Arl/+ 
neurons could be due to the reduced size of the neurons. 
 
  
 
 
          
 
          
Figure 23.  Graph of quantification of number of mitochondria in cell body of WT and Arl/+ 
neuronal cells. 
The number of mitochondria present in the cell body of neuronal cells from low magnification TEM 
images were counted and compared between WT and Arl/+ cells. n=15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
  
   
Figure 24.  Graph showing average neuron soma diameter in WT and Arl/+ spinal 
cord neurons. 
The diameter of the neuronal cell soma were measured using image J in WT and Arl/+ 
neuronal cell TEM micrographs and compared.  Arl/+ neuronal soma are significantly 
smaller compared to WT (p=0.03) (n=15). 
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At greater magnification (5,000 and 10,000 x) the mitochondria show a difference in 
morphology between the two genotypes, with a number of the Arl/+ mitochondria 
displaying an enlarged, elongated, deflated appearance, with less clearly defined 
cristae, compared to the WT (Figure 25).  The WT cells contain compact, mainly oval 
mitochondria.  
 
V.4 Measuring Rates of Respiration 
 
To investigate whether the morphological changes seen in the mitochondria affected the 
function, O2 consumption assays were performed to identify the rates of respiration in 
mitochondria from each genotype.  Using mitochondria, isolated from WT and Arl/+  
lumbar spinal cord by centrifugation, the rate of O2 consumption was measured on a 
Rank O2 electrode and the rates expressed as nmol O2.min
-1
mg of protein
-1
.  The 
mitochondria were isolated from lumbar spinal cord to ensure the mitochondria 
measured were comparable to those looked at using TEM.  The isolated mitochondria 
were pooled together from the lumbar spinal cords of five mice, and each experiment 
was repeated three times. 
 
Ascorbate and TMPD (tetramethyl pheylene diamine) are used to feed electrons to 
complex IV, cytochrome c oxidase.  TMPD is an artificial electron carrier which is 
reduced by ascorbate and oxidised by cytochrome c to feed electrons to complex IV.  
Cytochrome c oxidase is a large membrane bound dimeric enzyme, with each half 
consisting of 13 protein chains.  The complex acts as the terminal mitochondrial 
electron acceptor in the electron transport chain by accepting 4 electrons from 
cytochrome c, reducing an oxygen molecule. 
 
O2 + 4H
+
 + 4e
-
 → 2H2O 
 
This is coupled to the transfer of 4 protons across the mitochondrial membrane, to 
produce a membrane potential (Δψ), which is used to drive the synthesis of ATP.  Thus, 
the consumption of O2 at complex IV is a measure of the synthesis of ATP and the 
overall rate of respiration of the mitochondrion. 
 
 
  
Wildtype 
 
      
 
 
Arl/+ 
 
     
 
Figure 25.  TEM micrographs of mitochondria in WT and Arl/+ neuronal cells. 
In WT mitochondria are mainly oval shaped with clearly defined cristae, however, in Arl/+ cells, 
mitochondria are often elongated in shape and have ill-defined cristae.  Arrows indicate example 
mitochondria.  Scale bar = 1 µm. 
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As can be seen from Figure 26, the rate of respiration is significantly higher in the Arl/+ 
compared to the WT (p=0.0156).  This data suggests that there may be a greater energy 
requirement in the lumbar spinal cord neurons from Arl/+ compared to WT. 
 
V.5 Discussion 
 
In TEM Golgi appeared normal, with correct structure and location, suggesting fixation 
and dissection procedures did not perturb tissue.  At higher magnification, Golgi 
appears to be functioning normally, with secretory vesicles visible near the trans-Golgi.  
A large proportion of the Golgi appears normal in Arl/+ sections compared to the WT 
cells.  However, some cisternae are loosely packed with gaps between the stacks of 
membranes, suggesting that the Arl mutation affects dynein’s ability to maintain the 
normal fine structure of the Golgi. 
 
Such large gaps between the membranes of the Golgi could increase the distance 
between the cis and trans faces of the Golgi network and disrupt transport through the 
network.  Golgi is important for modification and labelling of proteins which are then 
packaged, at the trans Golgi network (TGN), for transport to the plasma membrane 
(e.g. for exocytosis) or secretory pathways.  Disruption of the structure of the Golgi 
could affect the labelling or modification of proteins, or impede their transport through 
the network.  This could lead to incorrectly modified proteins, or incorrect or reduced 
secretion.  In neuronal cells, the proteins secreted can include neurotransmitters, so any 
disruption to the Golgi could lead to perturbed neuronal function. 
 
To test the functioning of the Golgi, despite the disrupted structure, transport through 
the ER-Golgi pathway could be investigated.  Disruption to the function of the Golgi 
due to structural upset could affect the movement of proteins from the ER to the Golgi 
and subsequent transport through secretory or exocytic pathways.  This could be 
investigated by transfecting WT and Arl/+ cells with GFP-cDNA of a protein of 
interest.  The expressed GFP-protein will then be transported through the ER-Golgi 
pathway and can be tracked using live cell imaging to determine whether the Arl/+ 
cells are impaired in this transport compared to WT.  
 
 
  
 
 
 
 
 Figure 26.  Graph showing O2 consumption of WT and Arl/+ mitochondria 
Mitochondria were isolated from WT and Arl/+ lumbar spinal cord and O2 consumption assays 
performed to identify any difference between the genotypes.  Assay was performed 3 times on 
mitochondria isolated from 5 mice each time and shows that Arl/+ mitochondria consume 
significantly greater amounts of O2 compared to WT. 
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Dynein has been shown to be important for cellular distribution of mitochondria, and 
disruption of axonal transport leads to non-uniform distribution of mitochondria along 
the axon.  The retrograde transport of mitochondria is important for degradation and 
recycling and so dynein is essential in ensuring only functional mitochondria remain in 
cells. 
 
Although there is no significant difference in the number of mitochondria present in the 
cell bodies of Arl/+ compared with that in the WT it is important to determine whether 
this is true throughout the entire cell, or just the cell body.  Transport of mitochondria 
from axons to the cell body for degradation and the rate of degradation of mitochondria 
by autophagy should be investigated.  The mitochondrial biogenesis is a balance 
between synthesis and degradation and determines the number of mitochondria in a 
cell.  If autophagy of mitochondria is increased, but synthesis levels remain static, then 
overall numbers of mitochondria will decrease.  To determine this, the number of 
mitochondria in entire neurons would need to be established to see if either the 
distribution of mitochondria between axons and cells bodies is different or the total 
number of mitochondria is different, or whether there is no difference between 
genotypes. 
 
A decrease in dynein retrograde transport, but continued levels of kinesin anterograde 
transport would have the net effect of decreasing the number of mitochondria at the cell 
body.  However, studies have shown that perturbed dynein transport can have an effect 
on kinesin, so rates of both anterograde and retrograde transport in Arl/+ and WT 
neurons would need to be established to determine the balance of transport (Gross, 
Welte et al. 2002). 
 
Unpublished data from Bros-Facer et al. (Bros-Facer, Golding et al. Manuscript in 
preparation) have shown a shift towards a greater number of smaller motor neurons in 
Arl/+ lumber spinal cord.  These motor neurons were 20% smaller in Arl/+ compared 
to WT.  This trend was also identified in the neurons from the lumbar spinal cords used 
for TEM, which were measured and showed that Arl/+ neuronal soma were 
significantly smaller than WT. 
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The mitochondria were then analysed at greater magnification to determine if the Arl 
mutation has an effect on mitochondria morphology.  At 5000 x and 10000 x 
magnification the mitochondria show a difference in morphology between the two 
genotypes.  While the majority of WT mitochondria maintain an oval, turgid 
appearance with well defined cristae, a number of Arl/+ mitochondria display an 
enlarged, elongated appearance with some also exhibiting less well defined cristae. 
 
The elongated, tubular appearance of these mitochondria in Arl/+ cells could be due to 
increased fusion of unhealthy mitochondria with healthy ones, to produce healthy, 
functional mitochondria.  Alternatively, the enlarged mitochondria may be unhealthy, 
particularly those with less well defined cristae, and awaiting degradation by 
autophagy, rather than repair through fusion. 
 
Large mitochondria can arise during fission as new ones are produced.  Dynein has 
been implicated in mitochondrial fission by transporting the dynamin related protein 
Drp1 which is necessary for mitochondrial fission.  Varadi et al (Varadi, Johnson-
Cadwell et al. 2004) have shown that disrupting dynein function in HeLa cells results in 
the movement of mitochondria from the cell periphery to the cell centre.  It also results 
in the formation of long, and sometimes interconnected, mitochondria.  Drp1 is 
recruited to the outer membrane of mitochondria for fission to occur, but when the 
dynein complex is disrupted (either through disruption of DIC, or disruption of 
dynamitin to affect dynactin) it results in the repositioning of Drp1 from the 
mitochondria to other cytoplasmic membranes.  Therefore, the elongated, tubular 
mitochondria identified in Arl/+ cells could be due to mislocation of Drp1 resulting 
from impaired dynein function. 
 
To identify whether Drp1 is being relocated from mitochondrial membranes due to the 
Arl mutation, immunogold labelling TEM could be employed.  This technique allows 
samples to be fixed and processed such that the antigenicity of the proteins is 
maintained.  Sections can then be labelled with a primary antibody (in this case, against 
Drp1) and then with a secondary antibody conjugated to small gold particles (~5-10 nm 
in diameter).  When imaged using the TEM, the gold particles are visible, revealing the 
location of the proteins of interest.  This would provide information on the location of 
Drp1 and indicate whether the Arl mutation is resulting in mislocated Drp1. 
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To determine whether the morphological changes identified in mitochondria from Arl/+ 
cells affect their function, O2 consumption assays were utilised.  This assay indicates 
the rate of respiration from the mitochondria tested. 
 
Mitochondria were isolated from lumbar spinal cord of Arl/+ and WT mice to ensure 
the mitochondria used were comparable to those analysed by TEM.   
 
The Arl/+ mitochondria showed a significantly higher rate of respiration compared to 
WT.  This suggests that there is a greater energy requirement in lumbar spinal cord 
neurons from Arl/+ than WT.  This data is similar to that seen in Loa/+ mice, where 
mitochondrial respiration is increased in Loa/+ compared to WT (El-Kadi, Bros-Facer 
et al. 2010).  Together these data suggest a gain-of-function by mutant cytoplasmic 
dynein which results in higher functioning mitochondria. However, the reasons for this 
increase are yet to be fully understood and further investigations are required. 
 
The Loa mutation rescues the SOD1
G93A
 phenotype, and specifically has been shown to 
rescue mitochondrial defects in respiration and membrane potential.  However, Arl/+ 
has not been shown to significantly ameliorate SOD1
G93A
 phenotype.  Although it is 
worth noting that only muscle force, motor neuron units and fatigue profiles were  
assessed and other specific SOD1
G93A
 phenotypes may show improvement if tested. 
 
Measurements of Arl/SOD1
G93A
 rates of respiration would need to be established to 
identify if any increase in respiration can rescue this particular phenotype of SOD1.  It 
may be that mitochondrial dysfunction plays only a small part in the raft of phenotypes 
caused by SOD1, and that rescue of it produces only a minimal overall improvement.  
This could explain Arl showing a similar increase in respiration as Loa, over WT, but 
not showing a global amelioration of phenotype when crossed with SOD1 as Loa does.  
There may be other phenotypes in SOD1 that Loa is able to rescue, but Arl is not, 
resulting in an overall improvement in Loa/SOD
G93A
 that is not seen in Arl/SOD
G93A
.  
Further analyses on both Loa and Arl with SOD1 are required to establish how the 
mutations interact. 
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Interestingly, Miller and Sheetz (Miller and Sheetz 2004) have shown that ~90% of 
mitochondria with a high membrane potential move anterogradely in neurons.  While 
~80% of mitochondria exhibiting a low membrane potential move in a retrograde 
direction.  As the mitochondria in the Arl/+ lumbar spinal cord preparations have 
increased ATP production, indicated by the increased O2 consumption, their membrane 
potentials must be high to allow for the increased ATP production.  This may mean that 
anterograde transport of mitochondria is increased in Arl/+ mitochondria, resulting in 
fewer remaining in the cell body.  However, as no significant difference in 
mitochondrial number in the cell body was seen between genotypes, the total numbers 
would need to be established throughout the neuronal cells. 
 
Mitochondria with a low membrane potential may not be functioning correctly, and so 
an increase in their retrograde transport would deliver them to the cell body for 
degradation.  Tctex1 has been shown to interact with VDAC in the outer membrane of 
mitochondria (Schwarzer, Barnikol-Watanabe et al. 2002) and this interaction may 
regulate the binding of dynein, and therefore the retrograde transport of mitochondria, 
with a low membrane potential, for degradation. 
 
A recent study from Cleveland’s lab (Israelson, Arbel et al. 2010) has shown that 
mutant SOD1 directly binds to VDAC1 (a VDAC isoform), inhibiting conductance of 
the channel.  The reduced activity decreases the survival of SOD1 mice through 
accelerated disease onset. 
 
As reduced conductance by VDAC1 will decrease ATP synthesis and reduce membrane 
potential, this data correlates with the reduced O2 consumption and thus ATP synthesis 
identified in SOD1 (El-Kadi, Bros-Facer et al. 2010).  Spectrophotometric assays have 
corroborated this, by showing a decrease in complex IV activity in SOD1 compared to 
WT (Philpott, unpublished data).  This assay measures the redox changes of 
cytochrome c added to complex IV and provides an accurate assessment of its activity 
(Benit, Goncalves et al. 2006).   
 
This data suggests that binding of mutant SOD1 to VDAC1 plays a large role in the 
mitochondrial phenotype identified in SOD1 mice.  As already discussed, dynein has 
been shown to interact with VDAC, via Tctex1, and recent data has shown increased 
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affinity of Tctex1 for the dynein complex in Loa (Deng, unpublished data).  As Loa has 
been shown to partially rescue mitochondrial function and increase SOD1 lifespan, it 
suggests that increased binding of mutant dynein, via Tctex1, at VDAC may counteract 
the effects of mutant SOD1 binding. 
 
Amelioration of SOD1 phenotype in mitochondria may be brought about by increased 
respiration rates in Arl, however, effects of Arl on SOD1 in mitochondria have yet to be 
investigated.  As the Arl mutation is not near regions of accessory chain association or 
cargo binding, similar effects as Loa may not be expected. 
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Chapter VI 
 
 
FINAL DISCUSSION 
 
 
 
VI.1  Summary of data 
 
As the main retrograde motor protein in cells, cytoplasmic dynein is responsible for 
transporting a wide range of cargo towards the minus end of MTs.  Mutations in the 
heavy chain of dynein, such as Loa, Cra1 and Swl, have demonstrated that interfering 
with this motor protein can lead to disruptions in a broad array of cellular functions. 
 
This study has demonstrated that a new heavy chain mutation, located in a region away 
from the other well characterised mutations, also causes disruption to cellular transport.  
Arl is located in an area of unknown function, N-terminal to the motor domain.  
Analysis of DHC protein showed no difference in the levels present in brain or spinal 
cord of Arl/+ and WT and no effect on the integrity of the complex was identified using 
sucrose density gradient centrifugation of homogenised adult brain tissue. 
 
The dynein complex was purified from adult brain tissue, with all subunits present; 
however, ATPase activity and MT gliding could not be measured. Using purified 
dynein, MT binding was found to be greater in Arl/+ than WT, suggesting that the 
mutation may affect the structure of the motor domain resulting in a higher affinity for 
MTs. 
 
Studies of cargo transport in MEFs revealed that in situations of cellular stress, dynein 
dependent reassembly of Golgi is impaired in Arl/+ compared to WT.  The trafficking 
of endosomes in MEFs was investigated using fluorophore-tagged EGF in fixed cells, 
which showed a delay in the endosomes reaching the lysosomes for degradation in 
Arl/+ compared to WT.  In addition to this, live cell imaging of EGF positive 
endosomes revealed that in Arl/+ the average speed of transport is significantly slower 
compared to WT.  To further investigate the effects of the mutation on dynein cargo, 
mitochondria were labelled with Mitotracker, a mitochondrial specific fluorophore, and 
their movement tracked by live cell imaging.  Although not significant, a trend towards 
slower movement in Arl/+ compared to WT was identified.  Nevertheless, these studies 
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have shown that dynein transport is impaired across a range of cargos, suggesting that 
the effects of Arl on cargo transport are not specific to a particular cargo. 
 
The effects of the mutation were further examined in spinal cord neurons from tissue 
sections using TEM.  Small perturbations to Golgi structure were identified in Arl/+ 
neuronal cells, with the cisternae appearing loosely stacked and large gaps in between 
some of the stacks of membranes.  The untreated control MEFs used in the Golgi 
reassembly studies did not show any disruption, suggesting that Arl dynein is able to 
maintain the global positioning of Golgi, but unable to maintain the fine structure and 
organisation of the membranes. 
 
Mitochondria were found to have altered morphology in Arl/+ neurons, compared to 
WT, with an enlarged, elongated appearance.  In a number of these mitochondria, the 
cristae were less well defined.  No significant difference in the number of mitochondria 
in the cell centre was identified between Arl/+ and WT cells.  The Arl/+ mitochondria 
were found to have significantly higher rates of respiration, compared to WT, 
suggesting a greater energy requirement in these neurons. 
 
VI.2  Significance of results and conclusions 
 
A conformational change in AAA1 results from nucleotide hydrolysis, and causes 
knock-on conformational changes to neighbouring AAA domains.  This results in the 
movement of CC1, relative to CC2 in the stalk and the change in registry between the 
two coiled-coils dictates the affinity of the MTBD for MTs (Gibbons, Garbarino et al. 
2005).  The proposed linker domain that is suggested to swing across the face of the 
ring is close to the site of the Arl mutation.   
 
The mutation results in a change from hydrophobic tryptophan to the compact, polar 
arginine and is predicted to lie between two helices.  It is therefore reasonable that the 
mutation could cause the structure to twist and affect the stability of the structure.  A 
change in the structure at this location could affect the linker domain.  A change in the 
positioning of the linker domain could affect the conformational state of the AAA1 
domain, which is directly C-terminal to it.  Perturbation of the conformation of AAA1 
could alter the knock-on conformational change around the ring, thus affecting the stalk 
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and the affinity of the MTBD.  Furthermore, if the movement of the linker domain is 
affected by the mutation, it may impede the powerstroke and thus the movement of 
dynein. 
 
Under zero load, dynein mainly moves in steps of 24 nm and 32 nm.  Under load, size 
step can decrease to 8 nm, suggesting that dynein can act as a molecular gear (Mallik, 
Carter et al. 2004).  The model for this gear suggests that load-induced ATP binding 
tightens the AAA ring, resulting in a smaller but stronger step of the motor.  Hence, any 
alteration in the conformation of the AAA domains due to the mutation could affect the 
step size (see Figure 27 below). 
 
Figure 27.  Flow chart of suggested effects of mutation on dynein structure and function. 
 
 
Change in 
structure due 
to mutation 
Affects linker 
domain 
structure 
Affects AAA1 
conformation 
Causes knock-on effect 
in conformation around 
AAA ring to stalk 
Affects ability of 
dynein to produce 
powerstroke (and 
therefore movement) 
due to impaired ATP 
binding/hydrolysis 
Affects CC1, changing 
position relative to CC2, 
resulting in sustained high 
MT affinity conformation of 
MTBD 
Changes conformation of 
AAA ring resulting in high 
gear conformation and reduced 
step size 
Impedes 
powerstroke, 
reducing 
movement 
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The impairment in cargo transport seen in MEFs is unlikely to result from problems 
with cargo binding as the mutation is not near the area of cargo binding, meaning that 
decreased speed of dynein movement along the MT is more plausible.  However, there 
are a number of possibilities (see Figure 28), such as: 
- Increased MT binding (due to conformational changes detailed above), 
therefore slowing movement along the MT. 
- Problems with ATP binding and/or hydrolysis due to conformational 
changes therefore affecting the ATP dependent powerstroke, and impeding 
the movement. 
- The mutation affecting movement of the linker domain and therefore 
resulting in powerstroke swing impairment. 
- The proposed gear system of dynein may be affected, causing dynein to 
move in smaller steps along the MT, thus resulting in a slower speed. 
  
 
Figure 28.  Schematic of dynein showing proposed effect of Arl mutation.  
Asterisk denotes location of residue 1206, the location of the mutation in Arl.  The mutation may cause 
the chain to twist, thus affecting the normal structure.  This could have a knock-on effect on the flexibility 
of the linker domain (shown in purple), preventing it from bending at its normal angle.  This could alter 
the angle at which the linker domain joins the first AAA domain, and may cause a change in 
conformation which has a knock-on effect to neighbouring AAA domains.  The change in conformation 
of the ring of AAA domains may result in a change in the alignment of the coiled-coils.  This change in 
alignment of CC1 and CC2 may cause the MTBD to bind MTs with a higher affinity. 
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Mitochondria with a high membrane potential have been shown to move in a 
predominantly anterograde direction, while low membrane potential mitochondria move 
in a mainly retrograde direction (Miller and Sheetz 2004).  As Arl/+ mitochondria have 
been shown to have increased rates of respiration, and therefore increased membrane 
potential, it suggests that these mitochondria would be undergoing higher levels of 
anterograde transport.  However, further studies are needed to identify any differences 
in kinesin- and dynein-dependent mitochondrial movement between genotypes. 
 
In conclusion, this study provides evidence for increased affinity of Arl/+ dynein for 
MTs, and that this reduces the speed at which cargo can be transported in MEFs.  In 
addition to this, mitochondria are mislocated with abnormal morphology in Arl/+ spinal 
cord neurons and demonstrate increased rates of respiration compared to WT.  This 
study also demonstrates that a mutation in dynein at a location far from other well 
characterised dynein mutations can result in similar phenotypes, highlighting the 
importance of the proper functioning of this protein. 
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VI.3  Future directions 
 
To determine how the mutation is affecting the protein, it is important to identify what 
effect the mutation has on the structure.  The region containing the mutation has been 
cloned from Arl and WT, but needs to be expressed and crystallised to allow x-ray 
diffraction patterns to be obtained.  From these, structures can be determined and any 
effect due to the mutation ascertained.  An alternative method to determine the effect of 
the mutation of the structure is the use of single molecule EM.  This would allow the 
structure of the molecule to be established in different conformations, thereby 
determining its three-dimensional structure and allowing any effect of the mutation to 
be identified. 
 
As AAA1 is the main site of ATP binding and hydrolysis, it is important to establish 
whether ATP hydrolysis is affected in Arl.  The ATPase assay in Chapter III is an ideal 
system to utilise, but dynein needs to be purified that is fully functioning and a suitable 
positive control must be identified.  Alternatively, other methods of measuring ATPase 
activity could be used, such as radioactive assays that measure 
32
P hydrolysed from 
ATP, or non-radioactive methods such as the spectrophotometric assay using malachite 
green. 
 
To establish whether the mutation causes the dynein to move in smaller steps along the 
MTs, studies using an optical trap should be utilised.  This would allow the step size of 
dynein to be determined in Arl and WT, and compare any differences in the force 
exerted by the motor.  This would provide information on whether the gear mechanism 
of dynein is affected by the mutation. 
 
As the mutation appears to affect the movement of dynein, rather than its association 
with cargo, it suggests that transport of all cargo would be affected.  Further studies to 
determine the effect on other cargo could be performed, such as transport of MTs as 
cargo and whether there is an effect on mitosis.  As transport of endosomes has been 
shown to be impaired, then downstream signalling could be disrupted by delayed 
trafficking of signalling factors.  EGFR signalling is vital for a large number of 
signalling pathways and detailed examination could be performed to identify possible 
cellular effects of delayed signalling. 
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Currently, all in vitro studies of cargo transport have been performed using MEFs.  Due 
to the large distances in neurons, particularly the axons, they can be more susceptible to 
defects in transport mechanisms.  Studies on cargo transport should therefore be 
performed using both motor and sensory neurons, to determine the effects of the 
mutation on these cells. 
 
The increased rate of respiration in Arl mitochondria, compared to WT, is similar to 
results obtained from Loa (El-Kadi, Bros-Facer et al. 2010).  Further studies are 
required to determine why and how respiration is increased and comparisons with Loa 
could be useful in this respect.  Additional analyses of Arl/SOD1 interactions may also 
help determine the nature of the effects of dynein mutations on mitochondria.  
Experiments such as dissecting the electron transport chain (ETC) would allow the 
function of each complex of the ETC to be checked, helping to identify the reason for 
increased respiration. 
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